<SEC-DOCUMENT>0001193125-24-071355.txt : 20240319
<SEC-HEADER>0001193125-24-071355.hdr.sgml : 20240319
<ACCEPTANCE-DATETIME>20240319163107
ACCESSION NUMBER:		0001193125-24-071355
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20240314
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240319
DATE AS OF CHANGE:		20240319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DELCATH SYSTEMS, INC.
		CENTRAL INDEX KEY:			0000872912
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				061245881
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16133
		FILM NUMBER:		24763893

	BUSINESS ADDRESS:	
		STREET 1:		566 QUEENSBURY AVENUE
		CITY:			QUEENSBURY
		STATE:			NY
		ZIP:			12804
		BUSINESS PHONE:		(518) 743-8892

	MAIL ADDRESS:	
		STREET 1:		566 QUEENSBURY AVENUE
		CITY:			QUEENSBURY
		STATE:			NY
		ZIP:			12804

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DELCATH SYSTEMS INC
		DATE OF NAME CHANGE:	19990607
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d784354d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dcth="http://www.delcath.com/20240314" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2024-03-14_to_2024-03-14">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-320">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-03-14_to_2024-03-14">0000872912</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="dcth-20240314.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-03-14_to_2024-03-14"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-03-14</xbrli:startDate> <xbrli:endDate>2024-03-14</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, DC 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-331">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-03-14_to_2024-03-14" format="ixt:datemonthdayyearen" id="ixv-332">March&#160;14, 2024</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-333">DELCATH SYSTEMS, INC.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-03-14_to_2024-03-14" format="ixt-sec:stateprovnameen" id="ixv-334">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-335">001-16133</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-336">06-1245881</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">incorporation or organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-337">566 Queensbury Avenue</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-338">Queensbury</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-339"><ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-03-14_to_2024-03-14" format="ixt-sec:stateprovnameen" id="ixv-340">New York</ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-341">12804</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices)</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-342">(212)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-343">489-2100</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-03-14_to_2024-03-14" format="ixt-sec:boolballotbox" id="ixv-344">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-03-14_to_2024-03-14" format="ixt-sec:boolballotbox" id="ixv-345">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-03-14_to_2024-03-14" format="ixt-sec:boolballotbox" id="ixv-346">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-03-14_to_2024-03-14" format="ixt-sec:boolballotbox" id="ixv-347">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-348">Common Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-349">DCTH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">The Nasdaq Capital Market</span> </td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR <span style="white-space:nowrap">&#167;240.12b-2).</span></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-03-14_to_2024-03-14" format="ixt-sec:boolballotbox" id="ixv-350">&#9744;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Securities Purchase Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;14, 2024, Delcath Systems, Inc. (the &#8220;Company&#8221;) and certain accredited investors (each an &#8220;Investor&#8221; and collectively, the &#8220;Investors&#8221;) entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) pursuant to which the Company agreed to sell and issue to the Investors in a private placement (the &#8220;Private Placement&#8221;) (i) an aggregate of 876,627 shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;), at a purchase price of $3.72 per share, and (ii)&#160;to certain investors, in lieu of shares of Common Stock, 1,008,102 <span style="white-space:nowrap">pre-funded</span> warrants (the <span style="white-space:nowrap">&#8220;Pre-Funded</span> Warrants&#8221;) at a price per <span style="white-space:nowrap">Pre-Funded</span> Warrant of $3.71 (the &#8220;Warrant Shares&#8221; and together with the Shares, the &#8220;Securities&#8221;). The <span style="white-space:nowrap">Pre-Funded</span> Warrants will have an exercise price of $0.01 per share of Common Stock, be immediately exercisable and remain exercisable until exercised in full. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Placement closed on March&#160;19, 2024. The Company received gross proceeds from the Private Placement of approximately $7&#160;million, before deducting offering expenses payable by the Company. The Company intends to use the net proceeds of the Private Placement for working capital and other general corporate purposes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Securities Purchase Agreement and the <span style="white-space:nowrap">Pre-Funded</span> Warrants does not purport to be complete and is qualified in its entirety by reference to the complete text of the Securities Purchase Agreement and the form of the <span style="white-space:nowrap">Pre-Funded</span> Warrant, which are attached hereto as Exhibits 10.1 and 4.1, respectively, to this Current Report on Form <span style="white-space:nowrap">8-K</span> and are hereby incorporated by reference into this Item 1.01. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Registration Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Private Placement, the Company and the Investors entered into a Registration Rights Agreement dated March&#160;14, 2024 (the &#8220;Registration Rights Agreement&#8221;), providing for the registration for resale of the Securities (including the shares of Common Stock underlying the <span style="white-space:nowrap">Pre-Funded</span> Warrants) that are not then registered on an effective registration statement, pursuant to a registration statement (the &#8220;Registration Statement&#8221;) to be filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on or prior to May&#160;13, 2024 (the &#8220;Filing Date&#8221;). The Company has agreed to use its best efforts to cause the Registration Statement to be declared effective as soon as possible, but in no event later than 75 days of the closing of the Private Placement (or 120 days in the event of a full review of the Registration Statement by the SEC) (the &#8220;Effectiveness Date&#8221;), and to keep the Registration Statement continuously effective for a period that extends from the first date on which the SEC issues an order of effectiveness in relation to the Registration Statement until such date that all registrable securities (as such term is defined in the Registration Rights Agreement) covered by the Registration Statement have been sold thereunder or pursuant to Rule 144 or may be sold without volume or <span style="white-space:nowrap"><span style="white-space:nowrap">manner-of-sale</span></span> restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event (i)&#160;the Registration Statement is not filed on or prior to the Filing Date, or (ii)&#160;the Company fails to file with the SEC a request for acceleration of a registration statement in accordance with Rule 461 promulgated under the Act within five trading days of the date that the Company is notified by the SEC that the Registration Statement will not be &#8220;reviewed&#8221; or will not be subject to further review, or (iii)&#160;prior to the effective date of the Registration Statement, the Company fails to file a <span style="white-space:nowrap">pre-effective</span> amendment and otherwise respond in writing to comments made by the SEC in respect of such Registration Statement within fifteen calendar days after the receipt of comments by or notice from the SEC that such amendment is required in order for such Registration Statement to be declared effective, or (iv)&#160;the Registration Statement is not declared effective by the Effectiveness Date, or (v)&#160;after the effective date of the Registration Statement, it ceases for any reason to remain continuously effective as to the Securities, or the holders are otherwise not permitted to utilize the prospectus therein to resell the Securities, for more than fifteen consecutive calendar days or more than an aggregate of twenty calendar days during any <span style="white-space:nowrap">12-month</span> period, then, until the applicable event is cured, the Company shall pay to each holder an amount in cash, as partial liquidated damages and not as penalty, equal to the product of 1.0% multiplied by the aggregate subscription amount paid by such holder pursuant to the Securities Purchase Agreement, subject to certain caps set forth in the Registration Rights Agreement. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has granted the Investors customary indemnification rights in connection with the Registration Statement. The Investors have also granted the Company customary indemnification rights in connection with the Registration Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the Registration Rights Agreement, a copy of which is filed as Exhibit 10.2 hereto and incorporated by reference into this Item 1.01. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;3.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Shares of Equity Securities. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained above in Item 1.01 relating to the Private Placement is hereby incorporated by reference into this Item 3.02. Based in part upon the representations of the Investors in the Securities Purchase Agreement, the offering and sale of the securities was made in reliance on the exemption afforded by Regulation D under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and corresponding provisions of state securities or &#8220;blue sky&#8221; laws. The Securities (including the shares of Common Stock underlying the <span style="white-space:nowrap">Pre-Funded</span> Warrants) have not been registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from the registration requirements. The sale of the Securities did not involve a public offering and was made without general solicitation or general advertising. The Investors represented that they are accredited investors, as such term is defined in Rule 501(a) of Regulation D under the Securities Act, and that they are acquiring the securities for investment purposes only and not with a view to any resale, distribution or other disposition of the securities in violation of the U.S. federal securities laws. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither this Current Report on Form <span style="white-space:nowrap">8-K</span> nor any exhibit attached hereto is an offer to sell or the solicitation of an offer to buy shares of Common Stock or other securities of the Company. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;15, 2024, the Company issued a press release announcing the Private Placement. The press release is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and incorporated into this Item 8.01 by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#8195;Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d784354dex41.htm">Form of <span style="white-space:nowrap">Pre-Funded</span> Warrant </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d784354dex101.htm">Form of Securities Purchase Agreement, dated March&#160;14, 2024, by and among Delcath Systems, Inc. and the persons party thereto </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d784354dex102.htm">Form of Registration Rights Agreement, dated March&#160;14, 2024, by and among Delcath Systems, Inc. and the persons party thereto </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d784354dex991.htm">Press Release, dated March&#160;15, 2024 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">DELCATH SYSTEMS, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: March&#160;19, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gerard Michel</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Gerard Michel</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d784354dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;SECURITIES ACT&#148;), OR UNDER APPLICABLE STATE SECURITIES OR BLUE SKY LAWS. THIS SECURITY AND THE SECURITIES
FOR WHICH THIS SECURITY IS EXERCISABLE ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PRE-FUNDED</FONT> COMMON STOCK PURCHASE WARRANT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELCATH SYSTEMS, INC. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Warrant Shares: [&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Issue Date: March&nbsp;19, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Initial Exercise Date: March&nbsp;19, 2024</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">THIS <FONT STYLE="white-space:nowrap">PRE-FUNDED</FONT> COMMON STOCK PURCHASE WARRANT (the
&#147;<U>Warrant</U>&#148;) certifies that, for value received, [&#149;] or its assigns (the &#147;<U>Holder</U>&#148;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after the date hereof (the &#147;<U>Initial Exercise Date</U>&#148;) and until this Warrant is exercised in full, to subscribe for and purchase from Delcath Systems, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), up to [&#149;]
shares of Common Stock (as subject to adjustment hereunder, the &#147;<U>Warrant Shares</U>&#148;). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section&nbsp;2(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set
forth in that certain Securities Purchase Agreement (the &#147;<U>Purchase Agreement</U>&#148;), dated March&nbsp;14, 2024, among the Company and the purchasers signatory thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;2</U>. <U>Exercise</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a) <U>Exercise of Warrant</U>. The Holder may exercise this Warrant, in whole or in part, at any time or times on or after the
Initial Exercise Date by delivery to the Company of a duly executed PDF copy submitted by <FONT STYLE="white-space:nowrap">e-mail</FONT> attachment of the Notice of Exercise in the form annexed hereto (the &#147;<U>Notice of Exercise</U>&#148;).
Within the number of Trading Days comprising the Standard Settlement Period (as defined in Section&nbsp;2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares
specified in the applicable Notice of Exercise by wire transfer or cashier&#146;s check drawn on a United States bank, in either case in immediately available funds, unless the cashless exercise procedure specified in Section&nbsp;2(c) below is
specified in the applicable Notice of Exercise.<B> </B>No <FONT STYLE="white-space:nowrap">ink-original</FONT> Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. The Company shall have no obligation to inquire with respect to or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
otherwise confirm the authenticity of the signature(s) contained on any Notice of Exercise nor the authority of the person so executing such Notice of Exercise. Notwithstanding anything herein to
the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder
shall surrender this Warrant to the Company for cancellation within three (3)&nbsp;Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of
the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the
Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1)&nbsp;Trading Day of receipt of such notice. <B>The Holder
and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b) <U>Exercise Price</U>. The
aggregate exercise price of this Warrant, except for a nominal exercise price of $0.01 per Warrant Share, was <FONT STYLE="white-space:nowrap">pre-funded</FONT> to the Company on or prior to the Initial Exercise Date and, consequently, no additional
consideration (other than the nominal exercise price of $0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The remaining unpaid exercise price per share of Common Stock under
this Warrant shall be $0.01, subject to adjustment hereunder (the &#147;<U>Exercise Price</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c) <U>Cashless
Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &#147;cashless exercise&#148; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing <FONT
STYLE="white-space:nowrap">[(A-B)</FONT> (X)] by (A), where: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(A)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">as applicable: (i)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)&nbsp;both executed and delivered pursuant to Section&nbsp;2(a) hereof on a day
that is not a Trading Day or (2)&nbsp;both executed and delivered pursuant to Section&nbsp;2(a) hereof on a Trading Day prior to the opening of &#147;regular trading hours&#148; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the
federal securities laws) on such Trading Day, (ii)&nbsp;at the option of the Holder, either (y)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z)&nbsp;the Bid Price of the Common Stock on the
principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&#146;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#147;regular trading hours&#148; on a Trading Day and is
delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours after the close of &#147;regular trading hours&#148; on a Trading Day) pursuant to Section&nbsp;2(a) hereof or (iii)&nbsp;the VWAP on the date of the applicable
Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section&nbsp;2(a) hereof after the close of &#147;regular trading hours&#148; on such Trading
Day;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(B)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(X)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Warrant Shares are issued in such a cashless exercise, the parties
acknowledge and agree that in accordance with Section&nbsp;3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may be tacked
on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section&nbsp;2(c). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bid Price</U>&#148; means, for any date, the price determined by the first of the following clauses that applies:
(a)&nbsp;if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as
reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the
nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock is then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>VWAP</U>&#148; means, for any date, the price determined by the first of the following clauses that applies:
(a)&nbsp;if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or
quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock is then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d) <U>Mechanics of Exercise</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">i. <U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be
transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#146;s or its designee&#146;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#147;<U>DWAC</U>&#148;) if
the Company&#146;s transfer agent is then a participant in such system and either (A)&nbsp;there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B)&nbsp;the
Warrant Shares are eligible for resale by the Holder without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and
otherwise by physical delivery of a certificate, registered in the Company&#146;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
in the Notice of Exercise by the date that is the then the number of Trading days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date,
the &#147;<U>Warrant Share Delivery Date</U>&#148;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been
exercised, irrespective of the date of delivery of the Warrant Shares, provided that the Company shall have received payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the number of Trading
Days comprising the Standard Settlement Period at the time of delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the
Company shall pay, beginning one Trading Day after the Warrant Share Delivery Date, to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock
on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such
Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#147;Standard
Settlement Period&#148; means the standard settlement period, expressed in a number of Trading Days, on the Company&#146;s primary Trading Market with respect to the Common Stock as in effect on the date of the delivery of the Notice of Exercise.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">ii. <U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall,
at the request of a Holder and upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares remaining available
under this Warrant, which new Warrant shall in all other respects be identical with this Warrant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section&nbsp;2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering
written notice to the Company at any time prior to the delivery of such Warrant Shares (in which case any liquidated damages payable under Section&nbsp;2(d)(i) shall no longer be payable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">iv. <U>Compensation for <FONT STYLE="white-space:nowrap">Buy-In</FONT> on Failure to Timely Deliver Warrant Shares Upon
Exercise</U>. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section&nbsp;2(d)(i) above pursuant to an
exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#146;s brokerage firm otherwise purchases for the Holder,
Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#147;<U><FONT STYLE="white-space:nowrap">Buy-In</FONT></U>&#148;), then the Company shall
(A)&nbsp;pay in cash to the Holder the amount, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
if any, by which (x)&nbsp;the Holder&#146;s total purchase price (including reasonable and customary brokerage commissions, if any) for the Common Stock so purchased exceeds (y)&nbsp;the amount
obtained by multiplying (1)&nbsp;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2)&nbsp;the price at which the sell order giving rise to such purchase obligation
was executed, and (B)&nbsp;at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to
the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases shares of Common Stock having a total purchase
price of $11,000 to cover a <FONT STYLE="white-space:nowrap">Buy-In</FONT> with respect to an attempted exercise of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)&nbsp;of the
immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the <FONT STYLE="white-space:nowrap">Buy-In</FONT>
and evidence of the amount of such loss. Nothing herein shall limit a Holder&#146;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive
relief with respect to the Company&#146;s failure to timely deliver Common Stock upon exercise of the Warrant as required pursuant to the terms hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">v. <U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the
exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount
equal to such fraction multiplied by the Exercise Price or round up to the next whole share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">vi. <U>Charges, Taxes and
Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the
name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse
it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for <FONT STYLE="white-space:nowrap">same-day</FONT> processing of any Notice of Exercise and all fees to the Depository Trust Company (or another
established clearing corporation performing similar functions) required for <FONT STYLE="white-space:nowrap">same-day</FONT> electronic delivery of the Warrant Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">vii. <U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the
timely exercise of this Warrant, pursuant to the terms hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">e) <U>Holder&#146;s Exercise Limitations</U>. The Company shall not effect
any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section&nbsp;2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the
applicable Notice of Exercise, the Holder (together with the Holder&#146;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#146;s Affiliates (such Persons, &#147;<U>Attribution Parties</U>&#148;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of such shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i)&nbsp;exercise of the
remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)&nbsp;exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company
(including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section&nbsp;2(e), beneficial ownership shall be calculated in accordance with Section&nbsp;13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section&nbsp;13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in
accordance therewith and the calculations required under this Section&nbsp;2(e). To the extent that the limitation contained in this Section&nbsp;2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the
Holder&#146;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance
with Section&nbsp;13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section&nbsp;2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A)&nbsp;the Company&#146;s most recent periodic or annual report filed with the Commission, as the case may be, (B)&nbsp;a more recent public announcement or filing by the Company or (C)&nbsp;a more recent
written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number
of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or
its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &#147;<U>Beneficial Ownership Limitation</U>&#148; shall be [4.99/9.99]% of the number of shares of Common Stock
outstanding immediately after giving effect to the issuance of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
Section&nbsp;2(e), provided that the Beneficial Ownership Limitation in no event exceeds 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of Common Stock upon exercise of this Warrant held by
the Holder and the provisions of this Section&nbsp;2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> day after such notice is
delivered to the Company. The provisions of this Section&nbsp;2(e) shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;2(e) to correct this Section&nbsp;2(e) (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this
paragraph shall apply to a successor holder of this Warrant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;3</U>. <U>Certain Adjustments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a) <U>Share Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a share
dividend or otherwise makes a distribution or distributions in respect of the Company&#146;s Common Stock (which, for avoidance of doubt, shall not include any Common Stock issued by the Company upon exercise of this Warrant), (ii)&nbsp;subdivides
outstanding shares of Common Stock into a larger number of shares, (iii)&nbsp;combines (including by way of reverse share split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&nbsp;issues by reclassification of Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately
before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the
aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section&nbsp;3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or <FONT STYLE="white-space:nowrap">re-classification.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b) <U>[RESERVED]</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c) <U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section&nbsp;3(a) above, if at any time the
Company grants, issues or sells any Common Stock Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record holders of Common Stock (the &#147;<U>Purchase Rights</U>&#148;), then the Holder will be
entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is
taken, the date as of which the record holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&#146;s right to participate in any such
Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result
of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d) <U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any
dividend or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of shares or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#147;<U>Distribution</U>&#148;), at any time after the issuance of this Warrant, then, in each such case, the Holder
shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately
before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&#146;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such
Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time,
if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation); provided, that the Holder&#146;s right to receive such Distribution shall terminate on, and shall not be held in abeyance for any period
subsequent to the Termination Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">e) <U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding,
(i)&nbsp;the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person (other than for the purpose of changing
the Company&#146;s name and/or the jurisdiction of incorporation of the Company or a holding company for the Company), (ii)&nbsp;the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other
disposition of all or substantially all of its assets in one or a series of related transactions, (iii)&nbsp;any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to
which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding shares of Common Stock, (iv)&nbsp;the Company,
directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or
exchanged for other securities, cash or property, or (v)&nbsp;the Company, directly or indirectly, in one or more related transactions consummates a share purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, <FONT STYLE="white-space:nowrap">spin-off,</FONT> merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of
Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such share purchase agreement or other business combination)
(each a &#147;<U>Fundamental Transaction</U>&#148;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the
occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section&nbsp;2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the
Company, if it is the surviving corporation, and any additional consideration (the &#147;<U>Alternate Consideration</U>&#148;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this
Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section&nbsp;2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a
Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall require any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#147;<U>Successor Entity</U>&#148;) to assume in writing all of the obligations of the Company under
this Warrant and the other Transaction Documents in accordance with the provisions of this Section&nbsp;3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any
limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of
Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &#147;Company&#148; shall refer instead to the Successor Entity), and may exercise every right
and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">f) <U>Calculations</U>. All calculations under this Section&nbsp;3 shall be made to the nearest cent or the nearest 1/100th of
a share, as the case may be. For purposes of this Section&nbsp;3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if
any) issued and outstanding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">g) <U>Notice to Holder</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">i. <U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this
Section&nbsp;3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement
of the facts requiring such adjustment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">ii. <U>Notice to Allow Exercise by Holder</U>. If (A)&nbsp;the Company shall
declare a dividend (or any other distribution in whatever form) on the Common Stock, (B)&nbsp;the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&nbsp;the Company shall authorize the granting to
all holders of Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D)&nbsp;the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (and all of its Subsidiaries, taken as a whole) is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E)&nbsp;the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days
prior to the applicable record or effective date hereinafter specified, a notice stating (x)&nbsp;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be
taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on which such reclassification, consolidation, merger,
sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their Common Stock for securities, cash or other property
deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action
required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or any of the Subsidiaries, the
Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of
such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;4</U>. <U>Transfer of Warrant</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a) <U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in
Section&nbsp;4(d) hereof and to the provisions of Section&nbsp;4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of
this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to
pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the
denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three
(3)&nbsp;Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b) <U>New Warrants</U>. This Warrant may be divided or combined with other
Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to
compliance with Section&nbsp;4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c) <U>Warrant Register</U>. The Company shall register this Warrant, upon
records to be maintained by the Company for that purpose (the &#147;<U>Warrant Register</U>&#148;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner
hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d) <U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this
Warrant, the transfer of this Warrant shall not be either (i)&nbsp;registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii)&nbsp;eligible for resale without
volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions or current public information requirements pursuant to Rule&nbsp;144, the Company may require, as a condition of allowing such
transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section&nbsp;5.7 of the Purchase Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">e) <U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this
Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities
Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;5</U>. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a) <U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any
voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section&nbsp;2(d)(i), except as expressly set forth in Section&nbsp;3. Without limiting any rights of a Holder to receive Warrant
Shares on a &#147;cashless exercise&#148; pursuant to Section&nbsp;2(c) or to receive cash payments pursuant to Section&nbsp;2(d)(i) and Section&nbsp;2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this
Warrant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b) <U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the
Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably
satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share
certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on
the next succeeding Trading Day. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d) <U>Authorized Shares</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
share capital a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full
authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take such reasonable action as may be necessary to assure that such Warrant
Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued
upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid
and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without
limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth
in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i)&nbsp;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase
in par value, (ii)&nbsp;take such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&nbsp;use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is
exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">e) <U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant
shall be determined in accordance with the provisions of the Purchase Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">f) [<U>RESERVED]</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">g) <U>Nonwaiver; Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of
Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#146;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to
comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys&#146; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">h) <U>Notices</U>. Any notice, request or other document required or
permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement. Any notice, request or other document required or permitted to be given or delivered to the
Company by the Holder shall be delivered via email to <U>dhoffman@delcath.com</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">i) <U>Limitation of Liability</U>. No
provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the
purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">j) <U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of
damages, will be entitled to seek specific performance of its rights under this Warrant. The Company agrees that monetary damages may not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant
and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">k) <U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced
hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from
time to time of this Warrant and shall be enforceable by such Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">l) <U>Amendment</U>. This Warrant may be modified or
amended or the provisions hereof waived with the written consent of the Company and the Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">n) <U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose,
be deemed a part of this Warrant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">o) <U>Facsimile and Electronic Signatures</U>. Facsimile and other electronically
scanned and transmitted signatures, including by email attachment, shall be deemed originals for all purposes of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">******************** </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows.</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer
thereunto duly authorized as of the date first above indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>DELCATH SYSTEMS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF EXERCISE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TO: DELCATH SYSTEMS, INC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) The undersigned
hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if
any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) Payment shall take the form of (check applicable box): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:15%; font-size:10pt; font-family:Times New Roman">[ ] in lawful money of the United States; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:15%; font-size:10pt; font-family:Times New Roman">[ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant Shares shall be delivered to the following DWAC Account Number: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:15%; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:15%; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) <U>Accredited Investor</U>. The undersigned is an &#147;accredited investor&#148; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[SIGNATURE OF HOLDER] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name of Investing Entity: ________________________________________________________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Signature of Authorized Signatory of Investing Entity</I>: __________________________________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name of Authorized Signatory: ____________________________________________________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of Authorized Signatory: _____________________________________________________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: ______________________________________________________________________________________ </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(To assign
the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.) </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(Please Print)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(Please Print)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Phone Number:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email Address:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: _______________ __, ______</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Holder&#146;s Signature: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Holder&#146;s Address: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d784354dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>HIS</SMALL> S<SMALL>ECURITIES</SMALL> P<SMALL>URCHASE</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> (this
&#147;<B><I>Agreement</I></B>&#148;) is dated as of March&nbsp;14, 2024, between <B>D<SMALL>ELCATH</SMALL> S<SMALL>YSTEMS</SMALL>, I<SMALL>NC</SMALL>.</B>, a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), and each purchaser identified
on the signature pages hereto (each, including its successors and assigns, a &#147;<B><I>Purchaser</I></B>&#148; and collectively, the &#147;<B><I>Purchasers</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, subject to the terms and conditions set forth in this Agreement and pursuant to
Section&nbsp;4(a)(2) of the Securities Act of 1933, as amended (the &#147;<B><I>Securities Act</I></B>&#148;), and Rule 506 promulgated thereunder, or National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> &#151; Prospectus Exemptions
(NI <FONT STYLE="white-space:nowrap">45-106),</FONT> as applicable, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully
described in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>N<SMALL>OW</SMALL>, T<SMALL>HEREFORE</SMALL>, I<SMALL>N</SMALL>
C<SMALL>ONSIDERATION</SMALL></B><SMALL></SMALL> of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as
follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.1</B>
<B>Definitions</B>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section&nbsp;1.1: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Acquiring Person</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;4.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Action</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(j). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Affiliate</I></B>&#148; means any Person that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Beneficial Ownership Limitation</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;2.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Board of Directors</I></B>&#148; means the board of directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Business Day</I></B>&#148; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New
York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#147;stay at home&#148;,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;shelter-in-place&#148;,</FONT></FONT> <FONT STYLE="white-space:nowrap">&#147;non-essential</FONT> employee&#148; or any other similar orders or restrictions or the closure of
any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such
day. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Cleansing Disclosure</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;4.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Closing</I></B>&#148; means the closing of the purchase and sale of the Securities pursuant to Section&nbsp;2.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Closing Date</I></B>&#148; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the
applicable parties thereto, and all conditions precedent to (i)&nbsp;the Purchasers&#146; obligations to pay the Subscription Amount and (ii)&nbsp;the Company&#146;s obligations to deliver the Securities, in each case, have been satisfied or waived.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Commission</I></B>&#148; means the United States Securities and Exchange
Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Common Stock</I></B>&#148; means the common stock of the Company, par value $0.01 per share, and any other class
of securities into which such securities may hereafter be reclassified or changed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Common Stock Equivalents</I></B>&#148;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at
any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Company Counsel</I></B>&#148; means Cooley LLP, with offices located at 55 Hudson Yards, New York, NY 10001-2157. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Disclosure Schedules</I></B>&#148; means the Disclosure Schedules of the Company delivered concurrently herewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Disclosure Time</I></B>&#148; means, (i)&nbsp;if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m.
(New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, and (ii)&nbsp;if this Agreement is signed between midnight (New York City
time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Effective Date</I></B>&#148; means the earliest of the date that (a)&nbsp;the initial Registration Statement registering for
resale all Shares and Warrant Shares has been declared effective by the Commission, (b)&nbsp;all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for the Company to be
in compliance with the current public information required under Rule 144 and without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions, (c)&nbsp;following the one year anniversary
of the Closing Date provided that a holder of Shares or Warrant Shares is not an Affiliate of the Company, or (d)&nbsp;all of the Shares and Warrant Shares may be sold pursuant to an exemption from registration under Section&nbsp;4(a)(1) of the
Securities Act without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions or under other applicable securities laws and Company Counsel has delivered to such holders a standing
written unqualified opinion that resales may then be made by such holders of the Shares and Warrant Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Evaluation Date</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Exempt Issuance</I></B>&#148; means the issuance of (a)&nbsp;shares of Common Stock or options to employees,
officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors or a majority of the members of a committee of <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors established for such purpose for services rendered to the Company, (b)&nbsp;securities upon the exercise or exchange of, or conversion of, any Securities issued hereunder and/or other
securities exercisable or exchangeable for, or convertible into, shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number
of such securities or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of such securities (other than pursuant to anti-dilution or similar </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provisions in outstanding on the date hereof), and (c)&nbsp;securities issued pursuant to acquisitions or strategic transactions approved by a majority of the
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors of the Company, acting in good faith, provided that such securities are issued (1)&nbsp;as &#147;restricted securities&#148; (as defined in Rule 144) and carry no registration rights
that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section&nbsp;4.13(a) herein, or (2)&nbsp;in a registered transaction, provided, in each case, that any such issuance shall only
be to Person(s) (or to the equity holders of such Person(s)) which is, itself or through its subsidiaries, is an operating company or an owner of an asset that the majority of the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors,
acting in good faith, have deemed to be synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing
securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>FCPA</I></B>&#148; means the Foreign Corrupt Practices Act of 1977, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>FDA</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(jj). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>FDCA</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(jj). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>GAAP</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(h). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Indebtedness</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(bb). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Intellectual Property Rights</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(p). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Legend Removal Date</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;4.1(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Liens</I></B>&#148; means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or
other restriction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Material Adverse Effect</I></B>&#148; shall have the meaning assigned to such term in Section&nbsp;3.1(b).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Material Permits</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(n). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT></I></B>&#148; means the Canadian Securities
Administrators&#146; Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> &#151; Prospectus Exemptions (NI <FONT STYLE="white-space:nowrap">45-106).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Per Share Purchase Price</I></B>&#148; equals $3.72. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Person</I></B>&#148; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint
venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Pharmaceutical Product</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(jj). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Proceeding</I></B>&#148; means an action, claim, suit, investigation or proceeding (including, without limitation, an informal
investigation or partial proceeding, such as a deposition), whether commenced or threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Registration Rights
Agreement</I></B>&#148; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers, in the form of <B>Exhibit B</B> attached hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Registration Statement</I></B>&#148; means a registration statement meeting the
requirements set forth in the Registration Rights Agreement and covering the resale by the Purchasers of the Shares and the Warrant Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Required Approvals</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(e). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Rule 144</I></B>&#148; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or
interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Rule 424</I></B>&#148; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or
interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>SEC Reports</I></B>&#148; shall have the meaning ascribed to such term in Section&nbsp;3.1(h). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Securities</I></B>&#148; means the Shares, the Warrants and the Warrant Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Shares</I></B>&#148; means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but
excluding the Warrant Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Short Sales</I></B>&#148; means all &#147;short sales&#148; as defined in Rule 200 of
Regulation SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Subscription Amount</I></B>&#148; means, as to each Purchaser, the aggregate amount to be paid for Shares and/or Warrants
purchased hereunder as specified below such Purchaser&#146;s name on the signature page of this Agreement and next to the heading &#147;<B><I>Subscription Amount,</I></B>&#148; in United States dollars and in immediately available funds (minus, if
applicable, a Purchaser&#146;s aggregate exercise price of the Warrants, which amounts shall be paid as and when such Warrants are exercised). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Subsidiary</I></B>&#148; means any subsidiary of the Company as set forth in the SEC Reports, and shall, where applicable, also
include any direct or indirect subsidiary of the Company formed or acquired after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Trading Day</I></B>&#148;
means a day on which the principal Trading Market is open for trading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Trading Market</I></B>&#148; means any of the
following markets or exchanges on which the shares of Common Stock are listed or quoted for trading on the date in question: the NYSE American, The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market or the New York
Stock Exchange, OTCQB or OTCQX, or the &#147;<B><I>Pink Sheets</I></B>&#148; published by OTC Markets Group, Inc. (or any successors to any of the foregoing). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Transaction Documents</I></B>&#148; means this Agreement, the Warrants, the Registration Rights Agreement, all exhibits and
schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Transfer Agent</I></B>&#148; means Equiniti Trust Company, LLC, the current transfer agent of the Company, and any successor
transfer agent of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>VWAP</I></B>&#148; means, for any date, the price determined by the first of the
following clauses that applies: (a)&nbsp;if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the
Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of
the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the
&#147;<B><I>Pink Sheets</I></B>&#148; published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Warrants</I></B>&#148; means the Common Stock <FONT
STYLE="white-space:nowrap">pre-funded</FONT> warrants delivered to the applicable Purchasers at the Closing in accordance with Section&nbsp;2.2(a) hereof, which Warrants shall be immediately exercisable until exercised in full, in the form of
<B>Exhibit A</B> attached hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Warrant Purchase Price</I></B>&#148; equals $3.71 subject to adjustment for reverse and
forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Warrant Shares</I></B>&#148; means the shares of Common Stock issuable upon exercise of the Warrants. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 2 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AND
SALE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.1</B> <B>Closing</B>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company
agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $6,801,004.74 of Shares and Warrants. Each Purchaser shall deliver to the Company, via wire transfer, immediately available funds equal to such
Purchaser&#146;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser, and the Company shall deliver, or cause to be delivered, to each Purchaser its respective Shares and Warrants, as determined pursuant to
Section&nbsp;2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section&nbsp;2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall
occur at the offices of Company Counsel or such other location as the parties shall mutually agree. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.2</B> <B>Deliveries</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> this Agreement duly executed by the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> a legal opinion of Company Counsel in a form reasonably acceptable to the Purchasers; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a
certificate or book entry statement evidencing a number of Shares equal to such Purchaser&#146;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> for each Purchaser of Warrants pursuant to Section&nbsp;2.1, a Warrant
registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&#146;s Subscription Amount applicable to the Warrants divided by the Warrant Purchase Price, with an exercise price
equal to $0.01, subject to adjustment therein (such original Warrant may be delivered within two Trading Days after the Closing Date); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> the Company shall have provided each Purchaser with the Company&#146;s wire instructions, on Company letterhead and executed by the
Chief Executive Officer or Chief Financial Officer; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(vi)</B> the Registration Rights Agreement duly executed by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> this Agreement duly executed by such Purchaser; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> such Purchaser&#146;s Subscription Amount by wire transfer to the account specified in the Company&#146;s wire instructions; and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> the Registration Rights Agreement duly executed by such Purchaser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.3</B> <B>Closing Conditions</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate as of such date); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have
been performed; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> the delivery by each Purchaser of the items set forth in Section&nbsp;2.2(b) of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being
met: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or
Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate as of such date); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been
performed; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> the delivery by the Company of the items set forth in Section&nbsp;2.2(a) of
this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> from the date hereof to the Closing Date, trading in the shares of Common Stock shall not have been suspended by the Commission or
the Company&#146;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on
securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or
escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it
impracticable or inadvisable to purchase the Securities at the Closing; provided, however, that &#147;stay at home&#148;, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;shelter-in-place&#148;</FONT></FONT> or any other
similar orders or restrictions at the direction of any governmental authority shall not be deemed to be a material adverse change so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New
York generally are open for use by customers on such day. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.1</B> <B>Representations and Warranties of the Company</B>. Except as set forth in the SEC Reports filed prior to the date of this
Agreement (without giving effect to any amendment to any such SEC Report filed on or after the date hereof and excluding any risk factor disclosures contained under the heading &#147;<B><I>Risk Factors,</I></B>&#148; any disclosure of risks included
in any &#147;forward-looking statements&#148; disclaimer or any other statements that are similarly cautionary, predictive or forward-looking in nature; it being further agreed that any information disclosed in any such SEC Document shall be deemed
disclosure only with respect to a Section of this Agreement to which the relevance of such information is reasonably apparent to the Company and the Purchasers from the text of such information contained in such SEC Report) and the Disclosure
Schedules, which Disclosure Schedules shall be deemed a part of this Agreement, the Company hereby makes the following representations and warranties to each Purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Subsidiaries</B>. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns,
directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, <FONT
STYLE="white-space:nowrap">non-assessable</FONT> and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction
Documents shall be disregarded. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Organization and Qualification</B>. The Company and each of the Subsidiaries is an entity
duly incorporated or otherwise organized, validly existing and, if applicable under the laws of the jurisdiction in which they are formed, in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite
power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation or default of any of the provisions of its respective certificate or articles of
incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the
nature of the business conducted or property owned by it makes such qualification necessary, except where </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i)&nbsp;a material adverse effect on the legality, validity or
enforceability of any Transaction Document, (ii)&nbsp;a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii)&nbsp;a
material adverse effect on the Company&#146;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &#147;<B><I>Material Adverse Effect</I></B>&#148;) and no
Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Authorization; Enforcement</B>. The Company has the requisite corporate power and authority to enter into and to consummate the
transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by
the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the
Company&#146;s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed
by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i)&nbsp;as limited by general
equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by laws relating to the availability of
specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>No Conflicts</B>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i)&nbsp;conflict with or violate any provision of the Company&#146;s or any
Subsidiary&#146;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default)
under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or
without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any
property or asset of the Company or any Subsidiary is bound or affected, or (iii)&nbsp;subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction
of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in
the case of each of clauses (ii)&nbsp;and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B>Filings, Consents and Approvals</B>. The Company is not required to obtain any consent, waiver, authorization or order of, give
any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents,
other than: (i)&nbsp;the filings required pursuant to Section&nbsp;4.5 of this Agreement, (ii)&nbsp;the filing with the Commission pursuant to the Registration Rights Agreement, (iii)&nbsp;the notice and/or application(s) to each applicable Trading
Market for the issuance and sale of the Securities and the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, (iv)&nbsp;the filing of Form D with the Commission, and (iv)&nbsp;such filings as are
required to be made under applicable state securities laws (collectively, the &#147;<B><I>Required Approvals</I></B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Issuance of the Securities</B>. The Securities are duly authorized and, when
issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the
Transaction Documents. The Warrant Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on
transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> <B>Capitalization</B>. The capitalization of the Company as of the date hereof is as set forth in the SEC Reports. The Company has
not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&#146;s stock option plans, the issuance of shares of Common Stock to
employees pursuant to the Company&#146;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person
has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities, there are no
outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to
subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common
Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the
Purchasers) and will not result in a right of any holder of the Company to adjust the exercise, conversion, exchange or reset price under any such securities. There are no outstanding securities or instruments of the Company or any Subsidiary that
contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company
does not have any stock appreciation rights or &#147;phantom stock&#148; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and
nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further
approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the
Company&#146;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&#146;s stockholders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> <B>SEC Reports; Financial Statements</B>. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section&nbsp;13(a) or 15(d) thereof, for the two (2)&nbsp;years preceding the date hereof (or such shorter period as the Company was required by
law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#147;<B><I>SEC Reports</I></B>&#148;) on a timely basis
or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the
Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally
accepted accounting principles applied on a consistent basis during the periods involved (&#147;<B><I>GAAP</I></B>&#148;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial
statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash
flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> <B>Material Changes; Undisclosed Events, Liabilities or Developments</B>. Since the date of the latest audited financial statements
included within the SEC Reports, except as set forth in the SEC Reports, (i)&nbsp;there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii)&nbsp;the Company has
not incurred any liabilities (contingent or otherwise) other than (A)&nbsp;trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B)&nbsp;liabilities not required to be reflected in the
Company&#146;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii)&nbsp;the Company has not altered its method of accounting, (iv)&nbsp;the Company has not declared or made any dividend or distribution of
cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v)&nbsp;the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company stock option plans. Except for the issuance of the Securities contemplated by this Agreement or as set forth in the SEC Reports, no event, liability, fact, circumstance, occurrence or development has occurred or
exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company
under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1)&nbsp;Trading Day prior to the date that this representation is made. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> <B>Litigation</B>. Except as reported in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or
investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory
authority (federal, state, county, local or foreign) (collectively, an &#147;<B><I>Action</I></B>&#148;). None of the Actions set forth in the SEC Reports (i)&nbsp;adversely affects or challenges the legality, validity or enforceability of any of
the Transaction Documents or the Securities or (ii)&nbsp;could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor, to the Company&#146;s
knowledge, any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the
knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> <B>Labor Relations</B>. No labor dispute exists or, to the knowledge of the
Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&#146;s or its Subsidiaries&#146; employees is a member of a union that relates
to such employee&#146;s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with
their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does
not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to
employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> <B>Compliance</B>. Neither the Company nor any Subsidiary: (i)&nbsp;is in default under or in violation of (and no event has
occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it
is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation
of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii)&nbsp;is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all
foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to
result in a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(m)</B> <B>Environmental Laws</B>. The Company and its Subsidiaries (i)&nbsp;are in compliance
with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions,
discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &#147;<B><I>Hazardous Materials</I></B>&#148;) into the environment, or otherwise relating to the
manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice
letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&#147;<B><I>Environmental Laws</I></B>&#148;); (ii) have received all permits licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses; and (iii)&nbsp;are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably
expected to have, individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(n)</B> <B>Regulatory Permits</B>. The Company and the
Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the
failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&#147;<B><I>Material Permits</I></B>&#148;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the
revocation or modification of any Material Permit. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(o)</B> <B>Title to Assets</B>. The Company and the Subsidiaries have good and
marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens,
except for (i)&nbsp;Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries, and (ii)&nbsp;Liens for the payment of
federal, state or other taxes, for which appropriate reserves </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the
Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except where the failure to be in compliance would not reasonably be expected to have a Material Adverse
Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(p)</B> <B>Intellectual Property</B>. The Company and the Subsidiaries have, or have rights to use, all patents, patent
applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective
businesses as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &#147;<B><I>Intellectual Property Rights</I></B>&#148;). Except as set forth in the SEC Reports, none of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2)&nbsp;years
from the date of this Agreement except as would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To
the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights, except in each case as would not reasonably be expected to have a
Material Adverse Effect. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in
the aggregate, reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(q)</B> <B>Insurance</B>. The Company and the Subsidiaries are
insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary for companies of the Company&#146;s size and in the businesses in which the Company and the Subsidiaries are
engaged, including, but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing
insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a material increase in cost. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(r)</B> <B>Transactions with Affiliates and Employees</B>. Except as set forth in the SEC Reports and with respect to the participation in
this Agreement as a Purchaser, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company
or any Subsidiary (other than for services as employees, officers and directors), has either directly or indirectly any interest in, or is a party to, any transaction that would be required to be disclosed as a related party transaction pursuant to
Rule 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated under the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(s)</B> <B>Sarbanes-Oxley;
Internal Accounting Controls</B>. The Company and the Subsidiaries are in compliance, in all material respects, with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof and as of the
Closing, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide
reasonable assurance that: (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization, and (iv)&nbsp;the recorded </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have
established disclosure controls and procedures (as defined in Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e))</FONT> for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that material information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the Commission&#146;s rules and forms. The Company&#146;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most
recently filed periodic report under the Exchange Act (such date, the &#147;<B><I>Evaluation Date</I></B>&#148;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers
about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined
in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(t)</B> <B>Certain Fees</B>. No brokerage or finder&#146;s fees or commissions are or will be payable by the Company or any Subsidiary to
any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any
fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(u)</B> <B>Private Placement</B>. Assuming the accuracy of the Purchasers&#146; representations and warranties set forth in
Section&nbsp;3.2, no registration under the Securities Act or other applicable securities laws is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and sale of the Securities
hereunder does not contravene the rules and regulations of the Trading Market. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> <B>Investment Company</B>. The Company is not,
and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &#147;investment company&#148; within the meaning of the Investment Company Act of 1940, as amended. The Company shall
conduct its business in a manner so that it will not become an &#147;investment company&#148; subject to registration under the Investment Company Act of 1940, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(w)</B> <B>Registration Rights</B>. Except as set forth on Schedule 3.1(w), other than to each of the Purchasers pursuant to the
Registration Rights Agreement, no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(x)</B> <B>Listing and Maintenance Requirements</B>. Except as provided in the SEC Reports, the Company has not, in the 12 months preceding
the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Common
Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established
clearing corporation) in connection with such electronic transfer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(y)</B> <B>Application of Takeover Protections</B>. Except as provided in the SEC
Reports, the Company is not aware of any applicable control share acquisition, business combination, poison pill or other similar anti-takeover provision under the Company&#146;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without
limitation as a result of the Company&#146;s issuance of the Securities and the Purchasers&#146; ownership of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(z)</B>
<B>Disclosure</B>. Except with respect to (i)&nbsp;the material terms and conditions of the transactions contemplated by the Transaction Documents and (ii)&nbsp;as set forth on the Disclosure Schedule, the Company confirms that neither it nor any
other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, <FONT STYLE="white-space:nowrap">non-public</FONT> information. The SEC
Reports do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The Company
understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in Section&nbsp;3.2 hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(aa)</B> <B>No
Integrated Offering</B>. Assuming the accuracy of the Purchasers&#146; representations and warranties set forth in Section&nbsp;3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i)&nbsp;the
Securities Act which would require the registration of any such securities under the Securities Act, or (ii)&nbsp;any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or
designated. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(bb)</B> <B>Solvency</B>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving
effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i)&nbsp;the fair saleable value of the Company&#146;s assets exceeds the amount that will be required to be paid on or in respect of the Company&#146;s
existing debts and other liabilities (including known contingent liabilities) as they mature, (ii)&nbsp;the Company&#146;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted
including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)&nbsp;the current cash flow of
the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no
knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. The SEC Reports set forth as
of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &#147;<B><I>Indebtedness</I></B>&#148; means
(x)&nbsp;any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of
indebtedness of others, whether or not the same are or should be reflected in the Company&#146;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business; and (z)&nbsp;the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with
respect to any Indebtedness. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(cc)</B> <B>Tax Status</B>. Except for matters that would not, individually or in the
aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i)&nbsp;has made or filed all United States federal, state and local income and all foreign income and franchise tax returns,
reports and declarations required by any jurisdiction to which it is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
declarations except for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been established by the Company, and (iii)&nbsp;has set aside on its books provision reasonably adequate for the payment of all
material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company or of any Subsidiary know of no basis for any such claim. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(dd)</B> <B>No General Solicitation</B>. Neither the Company nor any
Person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain other &#147;accredited
investors&#148; within the meaning of Rule 501 under the Securities Act or National Instrument <FONT STYLE="white-space:nowrap">45-106,</FONT> as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ee)</B> <B>Foreign Corrupt Practices</B>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary,
any agent or other person acting on behalf of the Company or any Subsidiary, has (i)&nbsp;directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political
activity, (ii)&nbsp;made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, or (iii)&nbsp;failed to disclose fully any contribution made by
the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ff)</B> <B>Accountants</B>. The Company&#146;s independent registered public accounting firm is Marcum LLP. To the knowledge and belief of
the Company, such accounting firm is a registered public accounting firm as required by the Exchange Act. To the knowledge and belief of the Company, such accounting firm (i)&nbsp;is a registered public accounting firm as required by the Exchange
Act and (ii)&nbsp;shall express its opinion with respect to the financial statements to be included in the Company&#146;s Annual Report for the fiscal year ended December&nbsp;31, 2023. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(gg)</B> <B>Acknowledgment Regarding Purchasers&#146; Purchase of Securities</B>. The Company acknowledges and agrees that each of the
Purchasers is acting solely in the capacity of an arm&#146;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or
fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with
the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&#146; purchase of the Securities. The Company further represents to each Purchaser that the Company&#146;s decision to enter into this
Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(hh)</B> <B>Acknowledgment Regarding Purchaser&#146;s Trading Activity</B>. Anything in this Agreement or elsewhere herein to the contrary
notwithstanding (except for Sections 3.2(e) and 4.14 hereof), it is understood and acknowledged by the Company that: (i)&nbsp;none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or
selling, long and/or short, securities of the Company, or &#147;derivative&#148; securities based on securities issued by the Company or to hold </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Securities for any specified term; (ii)&nbsp;past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or
&#147;derivative&#148; transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&#146;s publicly-traded securities; (iii)&nbsp;any Purchaser, and counter-parties
in &#147;derivative&#148; transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &#147;short&#148; position in the Common Stock, and (iv)&nbsp;each Purchaser shall not be deemed to have any affiliation with
or control over any arm&#146;s length counter-party in any &#147;derivative&#148; transaction. The Company further understands and acknowledges that (y)&nbsp;one or more Purchasers may engage in hedging activities at various times during the period
that the Securities are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z)&nbsp;such hedging activities (if any) could reduce the
value of the existing stockholders&#146; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of
the Transaction Documents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> <B>Regulation M Compliance</B>. The Company has not, and to its knowledge no one acting on its
behalf has, (i)&nbsp;taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii)&nbsp;sold,
bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii)&nbsp;paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(jj)</B> <B>FDA</B>. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&#147;<B><I>FDA</I></B>&#148;)
under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&#147;<B><I>FDCA</I></B>&#148;) that is manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company or any of its Subsidiaries
(each such product, a &#147;<B><I>Pharmaceutical Product</I></B>&#148;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable requirements
under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product
listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company&#146;s knowledge, threatened,
action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any
notice, warning letter or other communication from the FDA or any other governmental entity, which (i)&nbsp;contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging
of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii)&nbsp;withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales
promotional materials relating to, any Pharmaceutical Product, (iii)&nbsp;imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv)&nbsp;enjoins production at any facility of the Company or any of its
Subsidiaries, (v)&nbsp;enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi)&nbsp;otherwise alleges any violation of any laws, rules or regulations by the Company or any of its
Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all
applicable laws, rules and regulations of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the
Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(kk)</B> <B>Reserved</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ll)</B> <B>Stock Option Plans</B>. Each stock option granted by the Company under the Company&#146;s stock option plan was granted
(i)&nbsp;in accordance with the terms of the Company&#146;s stock option plan and (ii)&nbsp;with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and
applicable law. No stock option granted under the Company&#146;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or
otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(mm)</B> <B>Office of Foreign Assets Control</B>. Neither the Company nor any Subsidiary nor, to the Company&#146;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#147;<B><I>OFAC</I></B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(nn)</B> <B>U.S. Real Property Holding Corporation</B>. The Company is not and has never been a U.S. real property holding corporation
within the meaning of Section&nbsp;897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&#146;s request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(oo)</B> <B>Money Laundering</B>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, and the applicable money laundering statutes and applicable rules and regulations thereunder
(collectively, the &#147;<B><I>Money Laundering Laws</I></B>&#148;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money
Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(pp)</B> <B>No Disqualification
Events</B>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the
Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&#146;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the
Securities Act) connected with the Company in any capacity at the time of sale (each, an &#147;<B><I>Issuer Covered Person</I></B>&#148; and, together, &#147;<B><I>Issuer Covered Persons</I></B>&#148;) is subject to any of the &#147;<B><I>Bad
Actor</I></B>&#148; disqualifications described in Rule 506(d)(1)(i) to (viii)&nbsp;under the Securities Act (a &#147;<B><I>Disqualification Event</I></B>&#148;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company
has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(qq)</B> <B>Other Covered Persons</B>. The Company is not aware of any person
(other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(rr)</B> <B>Notice of Disqualification Events</B>. The Company will notify the Purchasers in writing, prior to the Closing Date of
(i)&nbsp;any Disqualification Event relating to any Issuer Covered Person and (ii)&nbsp;any event that would, with the passage of time, reasonably be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case of
which it is aware. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.2</B> <B>Representations and Warranties of the Purchasers</B>. Each Purchaser, for
itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Organization; Authority</B>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated
by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents
have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser,
and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i)&nbsp;as limited by general
equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by laws relating to the availability of
specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Understandings or Arrangements</B>. Such Purchaser understands that the Securities are &#147;restricted securities&#148; and have
not been registered under the Securities Act or any applicable state securities law and is acquiring such Securities as principal for his, her or its own account and not with a view to or for distributing or reselling such Securities or any part
thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or
indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting
such Purchaser&#146;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of
its business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Purchaser Status</B>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof
it is, and on each date on which it exercises any Warrants, it will be an &#147;accredited investor&#148; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Experience of Such Purchaser</B>. Such Purchaser, either alone or together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is
able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B>General Solicitation</B>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or
other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general
advertisement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Access to Information</B>. Such Purchaser acknowledges that it has had the opportunity to review the
Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded (i)&nbsp;the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company
concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii)&nbsp;access to information about the Company and its financial condition, results of operations, business,
properties, management and prospects sufficient to enable it to evaluate its investment; and (iii)&nbsp;the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is
necessary to make an informed investment decision with respect to the investment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> <B>Certain Transactions and Confidentiality</B>. Other than consummating the
transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the
securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the
transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of such Purchaser&#146;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#146;s assets, the representation set forth above shall
only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&#146;s
representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating
or borrowing shares in order to effect Short Sales or similar transactions in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company acknowledges and agrees that the
representations contained in this Section&nbsp;3.2 shall not modify, amend or affect such Purchaser&#146;s right to rely on the Company&#146;s representations and warranties contained in this Agreement or any representations and warranties contained
in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 4 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER
AGREEMENTS OF THE PARTIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.1</B> <B>Transfer Restrictions</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The Securities may only be disposed of in compliance with state and federal securities laws or other applicable securities laws. In
connection with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section&nbsp;4.1(b), the Company
may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the
effect that such transfer does not require registration of such transferred Securities under the Securities Act or is in compliance with applicable securities laws. As a condition of transfer, any such transferee shall agree in writing to be bound
by the terms of this Agreement and the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> The Purchasers agree to the imprinting, so long as is required by this Section&nbsp;4.1, of a legend on any of the Securities in the
following form: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.2 [NEITHER] THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE ]
[HAS NOT BEEN ] REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE OR WITH ANY SECURITIES REGULATOR IN ANY OTHER JURISDICTION IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE &#147;SECURITIES ACT&#148;), OR OTHER APPLICABLE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, OR THE REQUIREMENTS OF ANY OTHER APPLICABLE SECURITIES LAWS. THIS SECURITY [AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &#147;</B><B><I>ACCREDITED INVESTOR</I></B><B>&#148; AS
DEFINED IN RULE 501(A) UNDER THE SECURITIES ACT, NATIONAL INSTRUMENT <FONT STYLE="white-space:nowrap">45-106,</FONT> OR SECTION 73.3 OF THE SECURITIES ACT (ONTARIO), AS APPLICABLE, OR OTHER LOAN SECURED BY SUCH SECURITIES. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a
registered broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &#147;accredited investor&#148; as defined in Rule 501(a) under the Securities Act, National Instrument <FONT
STYLE="white-space:nowrap">45-106,</FONT> or Section&nbsp;73.3 of the <I>Securities Act</I> (Ontario), as applicable and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Securities to the pledgees or
secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required
of such pledge. At the appropriate Purchaser&#146;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the
Securities, including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable
provision of the Securities Act to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder, provided that the Company shall not be required to file more than one prospectus supplement in any
one fiscal quarter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Certificates or other instruments evidencing the Shares and Warrant Shares shall not contain any legend
(including the legend set forth in Section&nbsp;4.1(b) hereof): (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii)&nbsp;following any sale of
such Shares or Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Warrants), (iii) if such Shares or Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Warrants), or (iv)&nbsp;if such legend is
not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) or any other applicable securities laws. The Company shall cause its counsel to issue a
legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Warrant
is exercised at a time when there is an effective registration statement to cover the resale of the Warrant Shares, or if such Warrant Shares may be sold under Rule 144 (assuming cashless exercise of the Warrants), or if such legend is not otherwise
required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Warrant Shares shall be issued free of all legends. The Company agrees that
following the Effective Date or at such time as such legend is no longer required under this Section </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
4.1(c), it will, no later than the earlier of (i)&nbsp;two (2) Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period following the delivery by a
Purchaser to the Company or the Transfer Agent of a certificate or other instrument representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend (such date, the &#147;<B><I>Legend Removal Date</I></B>&#148;), deliver
or cause to be delivered to such Purchaser a certificate or other instrument representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer
Agent that enlarge the restrictions on transfer set forth in this Section&nbsp;4. Certificates or other instruments for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the
account of the Purchaser&#146;s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein, &#147;<B><I>Standard Settlement Period</I></B>&#148; means the standard settlement period, expressed in a number of
Trading Days, on the Company&#146;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Shares or Warrants Shares, as the case may be, issued with a restrictive legend. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> In addition to such Purchaser&#146;s other available remedies, the Company shall pay to a Purchaser, in cash, (i)&nbsp;as partial
liquidated damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the shares of Common Stock on the date such Securities are submitted to the Transfer Agent) delivered for removal of the restrictive legend
and subject to Section&nbsp;4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5)&nbsp;Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date until such certificate is delivered
without a legend and (ii)&nbsp;if the Company fails to (a)&nbsp;issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that is
free from all restrictive and other legends and (b)&nbsp;if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or
any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any
restrictive legend, then, an amount equal to the excess of such Purchaser&#146;s total purchase price (including brokerage commissions and other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses,
if any) for the Common Stock so purchased (including brokerage commissions and other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses, if any) (the
&#147;<B><I><FONT STYLE="white-space:nowrap">Buy-In</FONT> Price</I></B>&#148;) over the product of (A)&nbsp;such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by
(B)&nbsp;the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending on the
date of such delivery and payment under this clause (ii). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> Each Purchaser, severally and not jointly with the other Purchasers,
agrees with the Company that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities
are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein and the Registration Rights Agreement, and acknowledges that the removal of the restrictive legend from certificates
representing Securities as set forth in this Section&nbsp;4.1 is predicated upon the Company&#146;s reliance upon this understanding and compliance with any other applicable securities laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.3</B> <B>Furnishing of Information; Public Information</B>. Until the earliest of the time that (i)&nbsp;no Purchaser owns Securities or
(ii)&nbsp;the Warrants have expired, the Company covenants to maintain the registration of the Common Stock under Section&nbsp;12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the
applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.4</B> <B>Integration</B>. The Company shall not sell, offer for sale or solicit offers
to buy or otherwise negotiate in respect of any security (as defined in Section&nbsp;2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act
of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other
transaction unless shareholder approval is obtained before the closing of such subsequent transaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.5</B> <B>Securities Laws
Disclosure; Publicity</B>. The Company shall (a)&nbsp;by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby, (b)&nbsp;file a Current Report on Form
<FONT STYLE="white-space:nowrap">8-K,</FONT> including the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act, and (c)&nbsp;no later than March&nbsp;29, 2024, the Company shall file its Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023, disclosing the information in the Disclosure Schedules (the &#147;<B><I>Cleansing Disclosure</I></B>&#148;). From and after the issuance of the
Cleansing Disclosure, no Purchaser shall be in possession of any material <FONT STYLE="white-space:nowrap">non-public</FONT> information received from the Company, its Subsidiaries or any of their respective officers, directors, employees or agents.
In addition, effective upon the issuance of such Cleansing Disclosure, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its
Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with
each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent
of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such
disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.6</B> <B>Shareholder Rights Plan</B>. No claim will be made or enforced by the Company or, with the consent of the Company, any other
Person, that any Purchaser is an &#147;<B><I>Acquiring Person</I></B>&#148; under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in
effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the
Company and the Purchasers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.7 Reserved. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.8</B> <B>Use of Proceeds</B>. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital and
general corporate purposes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.9</B> <B>Indemnification of Purchasers</B>. Subject to the provisions of this Section&nbsp;4.8, the
Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of
such title or any other title), each Person who controls such Purchaser (within the meaning of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or
employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#147;<B><I>Purchaser Party</I></B>&#148;) harmless
from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#146; fees and costs of investigation that any such
Purchaser Party may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
suffer or incur as a result of or relating to (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other
Transaction Documents or (b)&nbsp;any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to
any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&#146;s representations, warranties or covenants under the Transaction Documents or any agreements or
understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud,
gross negligence or willful misconduct). If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the
Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the
defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x)&nbsp;the employment thereof has been specifically authorized by the Company in writing, (y)&nbsp;the Company has
failed after a reasonable period of time to assume such defense and to employ counsel or (z)&nbsp;in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the
position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1)&nbsp;for
any settlement by a Purchaser Party effected without the Company&#146;s prior written consent, which shall not be unreasonably withheld or delayed; or (2)&nbsp;to the extent, but only to the extent that a loss, claim, damage or liability is
attributable to any Purchaser Party&#146;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this
Section&nbsp;4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause
of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.10</B> <B>Reservation of Common Stock</B>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and
keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.11</B> <B>Listing of Common Stock</B>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of the
Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the
Shares and Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will
take such other action as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and
trading of its Common Stock on a Trading Market and will comply in all respects with the Company&#146;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the
Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing
corporation in connection with such electronic transfer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.12</B> <B>Reserved</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.13</B> <B>Subsequent Equity Sales</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> From the date hereof until thirty (30)&nbsp;days after the Effective Date (such applicable period, the &#147;<B><I>Restricted
Period</I></B>&#148;), neither the Company nor any Subsidiary shall (i)&nbsp;issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or (ii)&nbsp;file any registration statement or any
amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> During
the Restricted Period, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock (or a combination of units thereof) involving a Variable Rate
Transaction. &#147;<B><I>Variable Rate Transaction</I></B>&#148; means a transaction in which the Company (i)&nbsp;issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to
receive, additional shares of Common Stock either (A)&nbsp;at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the Common Stock at any time after the
initial issuance of such debt or equity securities or (B)&nbsp;with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of
specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii)&nbsp;enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of
credit, whereby the Company may issue securities at a future determined price. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect
damages. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Notwithstanding the foregoing, this Section&nbsp;4.13 shall not apply in respect of an Exempt Issuance, except that no
Variable Rate Transaction shall be an Exempt Issuance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.14</B> <B>Equal Treatment of Purchasers</B>. No consideration (including any
modification of the Transaction Documents) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to
the Transaction Documents who then own Securities. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.15</B> <B>Certain Transactions and Confidentiality</B>. Each Purchaser, severally and not jointly with the other Purchasers, covenants
that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the Company&#146;s securities during the period commencing with the execution of
this Agreement and ending at such time that both the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release and the Cleansing Disclosure, as described in Section&nbsp;4.5. Each Purchaser,
severally and not jointly with the other Purchasers, covenants, as applicable, to maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release and the Cleansing Disclosure, as described in Section&nbsp;4.5. Notwithstanding the foregoing and notwithstanding anything
contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i)&nbsp;no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the
Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release and the Cleansing Disclosure, as described in Section&nbsp;4.5, (ii) no Purchaser shall be restricted or
prohibited from effecting any transactions in any securities of the Company in accordance with applicable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release and the Cleansing Disclosure, as
described in Section&nbsp;4.5 and (iii)&nbsp;no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance of the initial press release and the
Cleansing Disclosure, as described in Section&nbsp;4.5. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#146;s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#146;s assets, the covenant set forth above shall only apply with respect to the portion of
assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.16</B> <B>Exercise Procedures</B>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures
required of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no <FONT
STYLE="white-space:nowrap">ink-original</FONT> Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants. The
Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.17</B> <B>Form D; Blue Sky Filings</B>. The Company agrees to timely file a Form D with respect to the Securities as required under
Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale
to the Purchasers at the Closing under applicable securities or &#147;<B><I>Blue Sky</I></B>&#148; laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.1</B>
<B>Termination</B>. This Agreement may be terminated by any Purchaser, as to such Purchaser&#146;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the
other parties, if the Closing has not been consummated on or before March&nbsp;29, 2024; <I>provided, however</I>, that no such termination will affect the right of any party to sue for any breach by any other party (or parties). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.2</B> <B>Fees and Expenses</B>. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if
any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for <FONT
STYLE="white-space:nowrap">same-day</FONT> processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any
Securities to the Purchasers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.3</B> <B>Entire Agreement</B>. The Transaction Documents, together with the exhibits and schedules
thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have
been merged into such documents, exhibits and schedules. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.4</B> <B>Notices</B>. Any and all notices or other communications or deliveries
required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a)&nbsp;the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or
email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b)&nbsp;the next Trading Day after the time of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day,
(c)&nbsp;the second (2nd)Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d)&nbsp;upon actual receipt by the party to whom such notice is required to be given. The address for such
notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material,
<FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form
<FONT STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.5</B> <B>Amendments; Waivers</B>. No provision of this Agreement may be waived,
modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers holding at least 50.1% in interest of the Shares based on the initial Subscription Amounts hereunder (or, prior to
the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a
Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall
be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers
shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section&nbsp;5.5 shall be binding upon each Purchaser and holder of Securities and the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.6</B> <B>Headings</B>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.7</B> <B>Successors and Assigns</B>. This Agreement shall be binding upon and inure to
the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may
assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions
of the Transaction Documents that apply to the &#147;<B><I>Purchasers.</I></B>&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.8</B> <B>No Third-Party Beneficiaries</B>. This
Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in
Section&nbsp;4.8 and this Section&nbsp;5.8. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.9</B> <B>Governing Law</B>. All questions concerning the construction, validity,
enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party
agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the
state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the
enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding
is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified
mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to
the obligations of the Company under Section&nbsp;4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the <FONT STYLE="white-space:nowrap">non-prevailing</FONT> party for its reasonable attorneys&#146; fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.10</B> <B>Survival</B>. The
representations and warranties contained herein shall survive the Closing and the delivery of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.11</B>
<B>Execution</B>. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the
other may be made by facsimile or by electronic delivery of a portable document format (PDF) file (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and
Records Act or other applicable law, e.g., www.docusign.com). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.12</B> <B>Severability</B>. If any term, provision, covenant or
restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and
shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such
term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.13</B> <B>Rescission and Withdrawal Right</B>. Notwithstanding anything
to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely
perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in
part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any Common Stock subject to any such rescinded exercise
notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&#146;s right to acquire such shares pursuant to such Purchaser&#146;s Warrant (including,
issuance of a replacement warrant certificate evidencing such restored right). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.14</B> <B>Replacement of Securities</B>. If any certificate or other instrument
evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a
new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.15</B>
<B>Remedies</B>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents.
The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific
performance of any such obligation the defense that a remedy at law would be adequate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.16</B> <B>Payment Set Aside</B>. To the extent
that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any
law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived
and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.17</B>
<B>Independent Nature of Purchasers&#146; Obligations and Rights</B>. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in
any way for the performance or <FONT STYLE="white-space:nowrap">non-performance</FONT> of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by
any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as
a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this
Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel
in its review and negotiation of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by
any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers
collectively and not between and among the Purchasers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.18</B> <B>Liquidated Damages</B>. The Company&#146;s obligations to pay any
partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact
that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.19</B> <B>Saturdays, Sundays, Holidays, etc</B>. If the last or appointed day for the
taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.20</B> <B>Construction</B>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to
revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any
amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other
similar transactions of the Common Stock that occur after the date of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.21</B> <B>WAIVER OF JURY TRIAL</B>. IN ANY
ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND
EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature pages follow.</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the
parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>DELCATH SYSTEMS, INC.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>Address for Notice</U>:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">E-mail:</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a copy to (which shall not constitute notice): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank; </I> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>signature page for purchaser follows</I>.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Purchaser signature pages to DCTH Securities Purchase Agreement</I>] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the undersigned have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name of Purchaser:
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Signature of Authorized Signatory of Purchaser</I>:
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name of Authorized Signatory:
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of Authorized Signatory:
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;
</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email Address of Authorized Signatory:
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;</U>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Notice to Purchaser: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Delivery of
Securities to Purchaser (if not same as address for notice): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subscription Amount: $_________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shares: _________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrant: _________________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99% </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF WARRANT </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF REGISTRATION RIGHTS AGREEMENT </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>d784354dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>HIS</SMALL> R<SMALL>EGISTRATION</SMALL> R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> (this
&#147;<B><I>Agreement</I></B>&#148;) is made and entered into as of March 14, 2024, by and between <B>D<SMALL>ELCATH</SMALL> S<SMALL>YSTEMS</SMALL>, I<SMALL>NC</SMALL>.</B>, a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), and each of
the several purchasers signatory hereto (each such purchaser, a &#147;<B><I>Purchaser</I></B>&#148; and, collectively, the &#147;<B><I>Purchasers</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the
&#147;<B><I>Purchase Agreement</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company and each Purchaser hereby agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B> <B>Definitions</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in
the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Advice</I></B>&#148; shall have the meaning set forth in Section&nbsp;6(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Effectiveness Date</I></B>&#148; means, with respect to the Initial Registration Statement required to be filed hereunder, the 75<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> calendar day following the date hereof (or, in the event of a &#147;full review&#148; by the Commission, the 120<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> calendar day following the
date hereof) and with respect to any additional Registration Statements which may be required pursuant to Section&nbsp;2(c) or Section&nbsp;3(c), the 60<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> calendar day following the date on which
an additional Registration Statement is required to be filed hereunder (or, in the event of a &#147;full review&#148; by the Commission, the 90<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> calendar day following the date such additional
Registration Statement is required to be filed hereunder); <I>provided, however</I>, that in the event the Company is notified by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to
further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise required above, provided, further,
if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Effectiveness Period</I></B>&#148; shall have the meaning set forth in Section&nbsp;2(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Event</I></B>&#148; shall have the meaning set forth in Section&nbsp;2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Event Date</I></B>&#148; shall have the meaning set forth in Section&nbsp;2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Filing Date</I></B>&#148; means, with respect to the Initial Registration Statement required hereunder, the 60<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> calendar day following the date hereof; provided, however, that if such day falls on a day that is not a Trading Day, then the Filing Date shall be the next succeeding Trading Day, and, with respect
to any additional Registration Statements which may be required pursuant to Section&nbsp;2(c) or Section&nbsp;3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related
to the Registrable Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Holder</I></B>&#148; or &#147;<B><I>Holders</I></B>&#148; means the holder or holders, as the
case may be, from time to time of Registrable Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Indemnified Party</I></B>&#148; shall have the meaning set forth in
Section&nbsp;5(c). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Indemnifying Party</I></B>&#148; shall have the meaning set forth in
Section&nbsp;5(c). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Initial Registration Statement</I></B>&#148; means the initial Registration Statement filed pursuant to
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Losses</I></B>&#148; shall have the meaning set forth in Section&nbsp;5(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Plan of Distribution</I></B>&#148; shall have the meaning set forth in Section&nbsp;2(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Prospectus</I></B>&#148; means the prospectus included in a Registration Statement (including, without limitation, a prospectus
that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A or Rule 430B promulgated by the Commission pursuant to the Securities Act), as amended or supplemented
by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective
amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Registrable Securities</I></B>&#148; means, as of any date of determination, (a)&nbsp;all Shares, (b)&nbsp;all Warrant Shares then
issued and issuable upon exercise of the Warrants (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein) and (c)&nbsp;any securities issued or then issuable upon any stock split, dividend or
other distribution, recapitalization or similar event with respect to the foregoing; <I>provided, however</I>, that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the
effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for so long as (a)&nbsp;a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under the
Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration Statement, (b)&nbsp;such Registrable Securities have been previously sold in accordance with Rule 144, or (c)&nbsp;such
Registrable Securities become eligible for resale without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions and without current public information pursuant to Rule 144, as
reasonably determined by the Company, upon the advice of counsel to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Registration Statement</I></B>&#148; means
any registration statement required to be filed hereunder pursuant to Section&nbsp;2(a) and any additional registration statements contemplated by Section&nbsp;2(c) or Section&nbsp;3(c), including (in each case) the Prospectus, amendments and
supplements to any such registration statement or Prospectus, including <FONT STYLE="white-space:nowrap">pre-</FONT> and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by
reference in any such registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Rule 415</I></B>&#148; means Rule 415 promulgated by the Commission pursuant to
the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Selling Stockholder Questionnaire</I></B>&#148; shall have the meaning set forth in Section&nbsp;3(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>SEC Guidance</I></B>&#148; means (i)&nbsp;any publicly-available written or oral guidance of the Commission staff, or any
comments, requirements or requests of the Commission staff and (ii)&nbsp;the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.</B> <B>Shelf Registration</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the
resale of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> (except if the Company is not then eligible to register for resale the Registrable Securities on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> in which case such registration shall be on another appropriate
form in accordance herewith, subject to the provisions of Section&nbsp;2(e)) and shall contain (unless otherwise directed by at least 60% in interest of the Holders) substantially the &#147;<B><I>Plan of Distribution</I></B>&#148; attached hereto as
Annex A and substantially the &#147;<B><I>Selling Stockholder</I></B>&#148; section attached hereto as Annex B; <I>provided, however</I>, that no Holder shall be required to be named as an &#147;underwriter&#148; without such Holder&#146;s express
prior written consent. Subject to the terms of this Agreement, the Company shall use its commercially reasonable efforts to cause a Registration Statement filed under this Agreement (including, without limitation, under Section&nbsp;3(c)) to be
declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its commercially reasonable efforts to keep such Registration Statement
continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement (i)&nbsp;have been sold, thereunder or pursuant to Rule 144, or (ii)&nbsp;may be sold without volume or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144
(the &#147;<B><I>Effectiveness Period</I></B>&#148;). The Company shall request in writing effectiveness of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall promptly notify the Holders via facsimile
or by <FONT STYLE="white-space:nowrap">e-mail</FONT> of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for
effectiveness of such Registration Statement. The Company shall, by 10:00 p.m. (New York City time) on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424.
Failure to so notify the Holder within one (1)&nbsp;Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an Event under Section&nbsp;2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Notwithstanding the registration obligations set forth in Section&nbsp;2(a), if the Commission informs the Company that all of the
Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single Registration Statement, the Company agrees to promptly inform each of the Holders thereof and use its
commercially reasonable efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> or such other form available to register for resale the Registrable Securities as a secondary offering; with respect to filing on Form <FONT STYLE="white-space:nowrap">S-3</FONT> or other appropriate form, and
subject to the provisions of Section&nbsp;2(d) with respect to the payment of liquidated damages; <I>provided, however</I>, that prior to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission
for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Notwithstanding any other provision of this Agreement and subject to the payment of liquidated damages pursuant to
Section&nbsp;2(d), if the Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that the Company
used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable
Securities to be registered on such Registration Statement will be reduced as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> First, the Company shall reduce or
eliminate any securities to be included other than Registrable Securities; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> Second, the Company shall reduce Registrable Securities represented by Shares
and the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants (applied, in the case that some Shares and the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants may be registered, to the Holders on a pro rata basis based on the total
number of unregistered Shares and the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants held by such Holders). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of
a cutback hereunder, the Company shall give the Holder at least five (5)&nbsp;Trading Days prior written notice along with the calculations as to such Holder&#146;s allotment. In the event the Company amends the Initial Registration Statement in
accordance with the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by the Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration
statements on Form <FONT STYLE="white-space:nowrap">S-3</FONT> or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> If: (i)&nbsp;the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial
Registration Statement without affording the Holders the opportunity to review and comment on the same as required by Section&nbsp;3(a) herein, the Company shall be deemed to have not satisfied this clause (i)), or (ii)&nbsp;the Company fails to
file with the Commission a request for acceleration of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five (5)&nbsp;Trading Days of the date that the Company is notified
(orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be &#147;reviewed&#148; or will not be subject to further review, or (iii)&nbsp;prior to the effective date of a Registration Statement, the
Company fails to file a <FONT STYLE="white-space:nowrap">pre-effective</FONT> amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement within fifteen (15)&nbsp;calendar days after the
receipt of comments by or notice from the Commission that such amendment is required in order for such Registration Statement to be declared effective or (iv)&nbsp;a Registration Statement registering for resale all of the Registrable Securities is
not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement, or (v)&nbsp;after the effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously
effective as to all Registrable Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than fifteen (15)&nbsp;consecutive
calendar days or more than an aggregate of twenty (20)&nbsp;calendar days (which need not be consecutive calendar days) during any <FONT STYLE="white-space:nowrap">12-month</FONT> period (any such failure or breach being referred to as an
&#147;<B><I>Event</I></B>&#148;, and for purposes of clauses (i)&nbsp;and (iv), the date on which such Event occurs, and for purpose of clause (ii)&nbsp;the date on which such five (5)&nbsp;Trading Day period is exceeded, and for purpose of clause
(iii)&nbsp;the date which such fifteen (15)&nbsp;calendar day period is exceeded, and for purpose of clause (v)&nbsp;the date on which such fifteen (15)&nbsp;or twenty (20)&nbsp;calendar day period, as applicable, is exceeded being referred to as an
&#147;<B><I>Event Date</I></B>&#148;), then, in addition to any other rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not
have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 1.0% multiplied by the aggregate Subscription
Amount paid by such Holder pursuant to the Purchase Agreement. The parties agree that the maximum aggregate liquidated damages payable to a Holder under this Agreement shall be 8.0% of the aggregate Subscription Amount paid by such Holder pursuant
to the Purchase Agreement for the Registrable Securities then held by such Holder. If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven (7)&nbsp;days after the date payable, the Company will pay
interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such interest
thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> If Form <FONT STYLE="white-space:nowrap">S-3</FONT> is not available for the
registration of the resale of Registrable Securities hereunder, the Company shall (i)&nbsp;register the resale of the Registrable Securities on another appropriate form and (ii)&nbsp;undertake to register the Registrable Securities on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> covering the Registrable Securities has been declared effective by the Commission. Unless the Company is not then eligible to register for resale the Registrable Securities on Form
<FONT STYLE="white-space:nowrap">S-3,</FONT> the Initial Registration Statement shall be filed on Form <FONT STYLE="white-space:nowrap">S-3.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or
affiliate of a Holder as an underwriter without the prior written consent of such Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B> <B>Registration Procedures</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Company&#146;s registration obligations hereunder, the Company shall: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Not less than five (5)&nbsp;Trading Days prior to the filing of each Registration Statement and not less than one (1)&nbsp;Trading
Day prior to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed to be incorporated therein by reference), the Company shall (i)&nbsp;furnish to each Holder copies
of all such documents proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders, (ii)&nbsp;cause its officers and directors, counsel and independent
registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act and (iii)&nbsp;use its
best efforts to reflect in each such document, when so filed with the Commission, such comments as each Holder reasonably proposed. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is notified of such objection in writing no later than five (5)&nbsp;Trading Days after the Holders have been so
furnished copies of a Registration Statement or one (1)&nbsp;Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements thereto. Each Holder agrees to furnish to the Company a completed
questionnaire in the form attached to this Agreement as <B>Annex C</B> (a &#147;<B><I>Selling Stockholder Questionnaire</I></B>&#148;) on a date that is not less than two (2)&nbsp;Trading Days prior to the Filing Date or by the end of the fourth
(4th) Trading Day following the date on which such Holder receives draft materials in accordance with this Section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> (i)
Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to
the applicable Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities,
(ii)&nbsp;cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424, (iii) respond as promptly as
reasonably possible to any comments received from the Commission with respect to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence from and
to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein which would constitute material <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or
any of its Subsidiaries), and (iv)&nbsp;comply in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement
during the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> If during the Effectiveness Period, the number of Registrable Securities at any
time exceeds 100% of the number of shares of Common Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the applicable Filing Date, an additional Registration
Statement covering the resale by the Holders of not less than the number of such Registrable Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> Notify the Holders of
Registrable Securities to be sold (which notice shall, pursuant to clauses (iii)&nbsp;through (vi) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably
possible (and, in the case of (i)(A) below, not less than one (1)&nbsp;Trading Day prior to such filing) and (if requested by any such Person) confirm such notice in writing no later than one (1)&nbsp;Trading Day following the day (i)(A) when a
Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed, (B)&nbsp;when the Commission notifies the Company whether there will be a &#147;review&#148; of such Registration Statement and
whenever the Commission comments in writing on such Registration Statement, and (C)&nbsp;with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii)&nbsp;of any request by the Commission or any
other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, (iii)&nbsp;of the issuance by the Commission or any other federal or state governmental authority of
any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose, (iv)&nbsp;of the receipt by the Company of any notification with respect
to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose, (v)&nbsp;of the occurrence of any event or
passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and (vi)&nbsp;of the
occurrence or existence of any pending corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best interest of the Company to allow continued
availability of a Registration Statement or Prospectus; <I>provided, however</I>, that in no event shall any such notice contain any information which would constitute material, <FONT STYLE="white-space:nowrap">non-public</FONT> information
regarding the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Use its commercially reasonable efforts to avoid the issuance of, or, if
issued, obtain the withdrawal of (i)&nbsp;any order stopping or suspending the effectiveness of a Registration Statement, or (ii)&nbsp;any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for
sale in any jurisdiction, at the earliest practicable moment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Furnish to each Holder, without charge, at least one conformed
copy of each such Registration Statement and each amendment thereto, including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested by such Person, and all exhibits
to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> Subject to the terms of this Agreement, the Company hereby consents to the use of
such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto, except after the
giving of any notice pursuant to Section&nbsp;3(d). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> Prior to any resale of Registrable Securities by a Holder, use its
commercially reasonable efforts to register or qualify or cooperate with the selling Holders in connection with the registration or qualification (or exemption from registration or qualification) of such Registrable Securities for the resale by the
Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period
and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify
generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such
jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of
certificates representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable
such Registrable Securities to be in such denominations and registered in such names as any such Holder may request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> Upon the
occurrence of any event contemplated by Section&nbsp;3(d), as promptly as reasonably possible under the circumstances taking into account the Company&#146;s good faith assessment of any adverse consequences to the Company and its stockholders of the
premature disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by
reference, and file any other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii)&nbsp;through (vi) of Section&nbsp;3(d) above to suspend the
use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as
is practicable. The Company shall be entitled to exercise its right under this Section&nbsp;3(j) to suspend the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant
to Section&nbsp;2(d), for a period not to exceed 60 calendar days (which need not be consecutive days) in any <FONT STYLE="white-space:nowrap">12-month</FONT> period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the
Securities Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act,
promptly inform the Holders in writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Holders are required to deliver a Prospectus in connection with
any disposition of Registrable Securities and take such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> The Company may require each selling Holder to furnish to the Company a certified
statement as to the number of shares of Common Stock beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the shares. During any periods that the Company is
unable to meet its obligations hereunder with respect to the registration of the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&#146;s request, any liquidated damages that
are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(m)</B> With a view to making available to each Holder the benefits of Rule 144 and any other similar rule or regulation of the Commission
that may at any time permit such Holder to sell securities of the Company to the public without registration, the Company agrees (until all of the Registrable Securities have been sold or transferred under a Registration Statement or pursuant to
Rule 144) to use its best efforts to: (i)&nbsp;make and keep public information available, as those terms are understood and defined in Rule 144; (ii) file with the Commission in a timely manner (or obtain extensions in respect thereof and file
within the applicable grace period) all reports and other documents required of the Company under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements; and (iii)&nbsp;furnish to such Holder, so long as
such Holder owns any Registrable Securities, promptly upon written request (A)&nbsp;a written statement by the Company, if true, that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange Act, (B)&nbsp;to
the extent not publicly available through the Commissions EDGAR database, a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with the Commission, and (C)&nbsp;such other
information as may be reasonably requested by such Holder in connection with such Holders compliance with any rule or regulation of the Commission which permits the selling of any such securities without registration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B> <B>Registration Expenses</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne by the Company whether
or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i)&nbsp;all registration and filing fees (including, without limitation,
fees and expenses of the Company&#146;s counsel and independent registered public accountants)&nbsp;(A) with respect to filings made with the Commission, (B)&nbsp;with respect to filings required to be made with any Trading Market on which the
Common Stock is then listed for trading, and (C)&nbsp;in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for the Company in
connection with Blue Sky qualifications or exemptions of the Registrable Securities), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery
expenses, (iv)&nbsp;fees and disbursements of counsel for the Company, (v)&nbsp;Securities Act liability insurance, if the Company so desires such insurance, and (vi)&nbsp;fees and expenses of all other Persons retained by the Company in connection
with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement
(including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable
Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other
costs of the Holders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B> <B>Indemnification</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Indemnification by the Company</B>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold
harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a result of a pledge or any failure to perform under a margin call of Common Stock),
investment advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each of them, each Person who controls any such Holder (within
the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally equivalent role of a Person
holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including,
without limitation, reasonable attorneys&#146; fees) and expenses (collectively, &#147;<B><I>Losses</I></B>&#148;), as incurred, arising out of or relating to (1)&nbsp;any untrue or alleged untrue statement of a material fact contained in a
Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated
therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2)&nbsp;any violation or alleged violation by the Company of the
Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i)&nbsp;such untrue
statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder&#146;s
proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood
that the Holder has approved <B>Annex A</B> hereto for this purpose) or (ii)&nbsp;in the case of an occurrence of an event of the type specified in Section&nbsp;3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise
unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in
Section&nbsp;6(d). The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such
indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in accordance with Section&nbsp;6(h).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Indemnification by Holders</B>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its
directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, agents or employees of such
controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement of a material fact contained in any
Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to
make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (i)&nbsp;to the extent, but only to the extent, that such untrue statement or omission is
contained in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii)&nbsp;to the extent, but only to the extent, that such information relates to such
Holder&#146;s information provided in the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration
Statement (it being understood that the Holder has approved <B>Annex A</B> hereto for this purpose), such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than the dollar
amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section&nbsp;5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission)
received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Conduct of Indemnification Proceedings</B>. If any Proceeding shall be brought
or asserted against any Person entitled to indemnity hereunder (an &#147;<B><I>Indemnified Party</I></B>&#148;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the &#147;<B><I>Indemnifying Party</I></B>&#148;)
in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with
defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally
determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially and adversely prejudiced the Indemnifying Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the
fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1)&nbsp;the Indemnifying Party has agreed in writing to pay such fees and expenses, (2)&nbsp;the Indemnifying Party shall have failed promptly to
assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3)&nbsp;the named parties to any such Proceeding (including any impleaded parties) include both such
Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying
Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense
thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written
consent, which consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party
is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding on terms reasonably satisfactory to such Indemnified Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the
Indemnifying Party, provided that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which such Indemnified Party is finally determined by a court of
competent jurisdiction (which determination is not subject to appeal or further review) not to be entitled to indemnification hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Contribution</B>. If the indemnification under Section&nbsp;5(a) or 5(b) is unavailable to an Indemnified Party or insufficient
to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party
and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a
material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such action,
statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&#146; or other fees or expenses incurred by such
party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section&nbsp;5(d) were determined by pro
rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities
be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section&nbsp;5 and the amount of any damages such Holder has otherwise been required to pay by reason
of such untrue or alleged untrue statement or omission or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to
the Indemnified Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.</B> <B>Miscellaneous</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Remedies</B>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this
Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under
this Agreement. Each of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that,
in the event of any action for specific performance in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Reserved</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c) Reserved. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Discontinued Disposition</B>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice
from the Company of the occurrence of any event of the kind described in Section&nbsp;3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is advised in
writing (the &#147;<B><I>Advice</I></B>&#148;) by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed; provided that the foregoing shall not prevent the sale, transfer or other
disposition of Registrable Securities by a Holder in a transaction that is exempt from, or not subject to, the registration requirements of the Securities Act, so long as such Holder does not and is not required to deliver the applicable Prospectus
or Registration Statement in connection with such sale, transfer or other disposition, as the case may be. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company
agrees and acknowledges that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject to the provisions of Section&nbsp;2(d). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B>Amendments and Waivers</B>. The provisions of this Agreement, including the
provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and the Holders of 50.1% or
more of the then outstanding Registrable Securities (for purposes of clarification, this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification or waiver
disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities
pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate
which of its Registrable Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of a
Holder or some Holders and that does not directly or indirectly affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates; <I>provided, however</I>,
that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of the first sentence of this Section&nbsp;6(e). No consideration shall be offered or paid to any Person to amend or consent
to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Notices</B>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be
delivered as set forth in the Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> <B>Successors and Assigns</B>. This Agreement shall inure to the benefit of
and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder without the prior written consent of all
of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights hereunder in the manner and to the Persons as permitted under Section&nbsp;5.7 of the Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> <B>No Inconsistent Agreements</B>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall
the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise
conflicts with the provisions hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> <B>Execution and Counterparts</B>. This Agreement may be executed in two or more
counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need
not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by <FONT STYLE="white-space:nowrap">e-mail</FONT> delivery of a &#147;.pdf&#148; format data file, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#147;.pdf&#148; signature page were an original thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> <B>Governing Law</B>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be determined in accordance with the provisions of the Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> <B>Cumulative Remedies</B>. The remedies provided
herein are cumulative and not exclusive of any other remedies provided by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> <B>Severability</B>. If any term, provision, covenant or restriction of this
Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be
affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(m)</B> <B>Headings</B>. The headings in this Agreement are for convenience only, do not
constitute a part of the Agreement and shall not be deemed to limit or affect any of the provisions hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(n)</B> <B>Independent
Nature of Holders&#146; Obligations and Rights</B>. The obligations of each Holder hereunder are several and not joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the
obligations of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a
partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by
this Agreement or any other matters, and the Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions. Each Holder shall be
entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of
a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or
requested to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder, solely, and not between the Company and the Holders collectively and not between and among
Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">******************** </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature pages follow.</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>DELCATH SYSTEMS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature pages of Holders follows.</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page of Holder to DCTH RRA</I>] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name of Holder:
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Signature of Authorized Signatory of Holder</I>: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;&#8195;&#8195;&#8195;&#8201;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name of Authorized Signatory: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of Authorized Signatory: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNEX A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Selling Stockholder, or the Selling Stockholders, of the securities and any of their pledgees, assignees and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> may, from time to time, sell any or all of their securities covered hereby on the principal trading market or any other stock exchange, market or
trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker dealer solicits purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block trades in which the broker dealer will attempt to sell the securities as agent but may position and resell
a portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker dealer as principal and resale by the broker dealer for its account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">settlement of short sales; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in transactions through broker dealers that agree with the Selling Stockholder to sell a specified number of such
securities at a stipulated price per security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholder may also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if
available, rather than under this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Broker-dealers engaged by the Selling Stockholder may arrange for other brokers dealers to
participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders (or, if any broker dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set
forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the sale of the securities or interests therein, the Selling Stockholder may enter into hedging transactions with
broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholder may also sell securities short and deliver these securities to
close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholder may also enter into option or other transactions with broker-dealers or other financial institutions
or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell
pursuant to this prospectus (as supplemented or amended to reflect such transaction). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders and any broker-dealers or agents that are involved in selling the
securities may be deemed to be &#147;underwriters&#148; within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities
purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly,
with any person to distribute the securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are required to pay certain fees and expenses that we incur incident to the registration
of the securities. We have agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We agreed to keep this prospectus effective continuously effective under the Securities Act until the date that all the resale securities
being offered by the Selling Stockholders (i)&nbsp;have been sold pursuant to this registration statement or pursuant to Rule 144, or (ii)&nbsp;may be sold without volume or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions pursuant to Rule 144 and without the requirement for us to be in compliance with the current public information requirement under Rule 144.
The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been
registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject
to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling Stockholders or any other person. We will make copies
of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNEX B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SELLING STOCKHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
common stock being offered by the selling stockholders are those previously issued to the selling stockholders, and those issuable to the selling stockholders, upon exercise of the warrants. For additional information regarding the issuances of
those shares of common stock and warrants, see &#147;Private Placement of Common Stock and Warrants&#148; above. We are registering the common stock in order to permit the selling stockholders to offer the shares for resale from time to time. Except
for the ownership of the common stock and the warrants, and as otherwise disclosed in the footnotes to the below table, the selling stockholders have not had any material relationship with us within the past three years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below lists the selling stockholders and other information regarding the beneficial ownership of the common stock by each of the
selling stockholders. The second column lists the number of common stock beneficially owned by each selling stockholder, based on its ownership of the common stock and warrants, as of March&nbsp;19, 2024, assuming exercise of the warrants held by
the selling stockholders on that date, without regard to any limitations on exercises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The third column lists the common stock being
offered by this prospectus by the selling stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the terms of a registration rights agreement with the selling
stockholders, this prospectus generally covers the resale of the sum of (i)&nbsp;the number of common stock issued to the selling stockholders in the &#147;Private Placement of Common Stock and Warrants&#148; described above and (ii)&nbsp;the
maximum number of common stock issuable upon exercise of the related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed with
the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants. The
fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with
the terms of a registration rights agreement with the selling stockholders, we are required to use commercially reasonable efforts to keep this registration statement continuously effective under the Securities Act until the date that all the
registrable securities covered by this registration statement (i)&nbsp;have been sold, hereunder or pursuant to Rule 144, or (ii)&nbsp;may be sold without volume or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions pursuant to Rule 144 and without the requirement for us to be in compliance with the current public information requirement under Rule 144.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the warrants, a selling stockholder may not exercise the warrants to the extent such exercise would cause such selling
stockholder, together with its affiliates and attribution parties, to beneficially own a number of common stock which would exceed [4.99/9.99]% of our then outstanding shares of common stock following such exercise, excluding for purposes of such
determination common stock issuable upon exercise of the warrants which have not been exercised. The number of shares in the second column does not reflect this limitation. The selling stockholders may sell all, some or none of their shares in this
offering. See &#147;Plan of Distribution.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="24%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="24%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="24%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B><I>Name&nbsp;of&nbsp;Selling</I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B><I>Stockholder</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Number&nbsp;of&nbsp;Common</I></B><br><B><I>Stock&nbsp;Owned&nbsp;Prior&nbsp;to</I></B><br><B><I>Offering</I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Maximum&nbsp;Number&nbsp;of</I></B><br><B><I>Common Stock to be</I></B><br><B><I>Sold&nbsp;Pursuant&nbsp;to&nbsp;this</I></B><br><B><I>Prospectus</I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><I>Number&nbsp;of&nbsp;Common</I></B><br><B><I>Stock Owned After</I></B><br><B><I>Offering</I></B></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNEX C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELCATH SYSTEMS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Selling Stockholder Notice and Questionnaire </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned beneficial owner of shares of common stock (the &#147;<B><I>Registrable Securities</I></B>&#148;) of Delcath Systems, Inc., a
Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) a registration statement (the
&#147;<B><I>Registration Statement</I></B>&#148;) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the &#147;<B><I>Securities Act</I></B>&#148;), of the Registrable Securities, in accordance with the terms of
the Registration Rights Agreement (the &#147;<B><I>Registration Rights Agreement</I></B>&#148;) to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below.
All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain
legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel
regarding the consequences of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned
beneficial owner (the &#147;<B><I>Selling Stockholder</I></B>&#148;) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUESTIONNAIRE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.
Name. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Full Legal Name of Selling Stockholder </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8195;&#8194;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Full Legal Name of Registered Holder (if not the same as (a)&nbsp;above) through which Registrable Securities are held:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8195;&#8194;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others
has power to vote or dispose of the securities covered by this Questionnaire): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8195;&#8194;<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. Address for Notices to Selling Stockholder: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="91%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Telephone:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fax:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Contact Person:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3. Broker-Dealer Status: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Are you a broker-dealer? </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8195;&#8199;Yes &#9744; No &#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> If &#147;yes&#148; to Section&nbsp;3(a), did you receive your Registrable Securities as compensation for investment banking
services to the Company? </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8195;&#8199;Yes &#9744; No &#9744; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Note</B>:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If &#147;no&#148; to Section&nbsp;3(b), the Commission&#146;s staff has indicated that you should be identified
as an underwriter in the Registration Statement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Are you an affiliate of a broker-dealer? </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8195;&#8199;Yes &#9744; No &#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of
business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities? </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8195;&#8199;Yes &#9744; No &#9744; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><B>Note</B>:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If &#147;no&#148; to Section&nbsp;3(d), the Commission&#146;s staff has indicated that you should be identified
as an underwriter in the Registration Statement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B> <B>Beneficial Ownership of Securities of the Company Owned
by the Selling Stockholder</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Except as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of
any securities of the Company other than the securities issuable pursuant to the Purchase Agreement. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Type and Amount of other securities beneficially owned by the Selling
Stockholder: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5. Relationships with the Company: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5%
of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">State any exceptions here: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8195;&#8195;&#8195;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the
information provided herein that may occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify the Company of any changes to the number of
securities held or owned by the undersigned or its affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing below, the undersigned consents to the disclosure of the
information contained herein in its answers to Items 1 through 5 and the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such
information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus and any amendments or supplements thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL> the undersigned, by authority duly given, has caused
this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Beneficial Owner:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#8195;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PLEASE EMAIL A PDF COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO: </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>d784354dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Delcath Systems Announces $7 Million Private Placement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;15, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEW YORK, March&nbsp;15, 2024 /PRNewswire/
&#151; Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that it has entered into a securities purchase agreement with certain accredited
investors comprised of existing investors, Delcath Executives and members of its Board of Directors, for a private placement transaction (the &#147;Private Placement&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g784354dsp001.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delcath will issue and sell 876,627 shares of its common stock (the &#147;Common Stock&#148;) at a price per share of
$3.72, and, to certain investors, in lieu of shares of Common Stock, 1,008,102 <FONT STYLE="white-space:nowrap">pre-funded</FONT> warrants to purchase up to 1,008,102 shares of Common Stock (the
<FONT STYLE="white-space:nowrap">&#147;Pre-Funded</FONT> Warrants&#148;) at a price per <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrant of $3.71. The <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants will have an exercise price
of $0.01 per share of Common Stock, be immediately exercisable and remain exercisable until exercised in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delcath expects to receive gross proceeds
from the Private Placement of approximately $7&nbsp;million before deducting offering expenses payable by Delcath. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delcath intends to use the net
proceeds from the Private Placement for working capital purposes and other general corporate purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Placement is expected to close on
March&nbsp;19, 2024, subject to the satisfaction of customary closing conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The securities to be sold in the Private Placement, including the
shares of common stock underlying the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants, have not been registered under the Securities Act of 1933, as amended, or state securities laws as of the time of issuance and may not be offered or
sold in the United States absent registration with the Securities and Exchange Commission (&#147;SEC&#148;) or an applicable exemption from such registration requirements. Delcath has agreed to file one or more registration statements with the SEC
registering the resale of the Common Stock and the shares issuable upon exercise of the <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants purchased in the Private Placement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Delcath Systems, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delcath Systems, Inc. is an
interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company&#146;s proprietary products, HEPZATO KIT (Hepzato (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Hepatic Delivery System for Melphalan percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side
effects during a PHP procedure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States, HEPZATO KIT is considered a combination drug and device product and is regulated and approved for
sale as a drug by the FDA. HEPZATO KIT is comprised of the chemotherapeutic drug melphalan and Delcath&#146;s proprietary Hepatic Delivery System (HDS). The HDS is used to surgically isolate the liver while simultaneously filtrating hepatic venous
blood during melphalan infusion and washout. The use of the HDS results in loco-regional delivery of a relatively high melphalan dose, which can potentially induce a clinically meaningful tumor response with minimal hepatotoxicity and reduce
systemic exposure. HEPZATO KIT is approved in the United States as a liver-directed treatment for adult patients with metastatic uveal melanoma (mUM) with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic
disease, or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation. <U>Please see the full Prescribing Information, including BOXED WARNING for the HEPZATO KIT.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In Europe, the device-only configuration of the HDS is regulated as a Class&nbsp;III medical device and is approved for sale under the trade name CHEMOSAT
Hepatic Delivery System for Melphalan, or CHEMOSAT, where it has been used in the conduct of percutaneous hepatic perfusion procedures at major medical centers to treat a wide range of cancers of the liver. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Safe Harbor / Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private
Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This press release contains forward-looking statements, which are subject to certain risks and uncertainties, that
can cause actual results to differ materially from those described, in particular, the statements regarding our Private Placement and expected gross proceeds and the expected uses of the proceeds from the Private Placement. The words
&#147;anticipate,&#148; &#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148;
&#147;should,&#148; &#147;target,&#148; &#147;will,&#148; &#147;would&#148; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Factors that may
cause such differences include, but are not limited to, uncertainties relating to: the Company&#146;s commercialization plans and its ability to successfully commercialize the HEPZATO KIT; the Company&#146;s successful management of the HEPZATO KIT
supply chain, including securing adequate supply of critical components necessary to manufacture and assemble the HEPZATO KIT; successful FDA inspections of the facilities of the Company and those of its third-party suppliers/manufacturers; the
Company&#146;s successful implementation and management of the HEPZATO KIT Risk Evaluation and Mitigation Strategy; the potential benefits of the HEPZATO KIT as a treatment for patients with primary and metastatic disease in the liver; the
Company&#146;s ability to obtain reimbursement for the HEPZATO KIT; and the Company&#146;s ability to successfully enter into any necessary purchase and sale agreements with users of the HEPZATO KIT. For additional information about these factors,
and others that may impact the Company, please see the Company&#146;s filings with the Securities and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exchange Commission, including those on Forms <FONT STYLE="white-space:nowrap">10-K,</FONT> <FONT
STYLE="white-space:nowrap">10-Q,</FONT> and <FONT STYLE="white-space:nowrap">8-K.</FONT> However, new risk factors and uncertainties may emerge from time to time, and it is not possible to predict all risk factors and uncertainties. Accordingly, you
should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the
date they are made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contact: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Relations Contact:
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ben Shamsian </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lytham Partners </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">646-829-9701</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>shamsian@lythampartners.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">C View original content to
download multimedia:<U> </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">https://www.prnewswire.com/news-releases/delcath-systems-announces-7-million-private-placement-302090133.html
</FONT></FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE Delcath Systems, Inc. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>dcth-20240314.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/19/2024 11:04:21 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:dcth="http://www.delcath.com/20240314"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.delcath.com/20240314"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dcth-20240314_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dcth-20240314_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>dcth-20240314_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/19/2024 11:04:21 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>dcth-20240314_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/19/2024 11:04:21 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="dcth-20240314.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g784354dsp001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g784354dsp001.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @,# @(# @(" P0# P,#! 0$ @,$! 0$! ,$! ,! @(" @(" @(" @,"
M @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# __$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M>EET:[];]Q[>5B89]/R]JM?D+86@ H * "@ H * "@ H * "@""9R@^5MIR
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M;!M\@W8['CV_I5:]@M;RL+G_ #Z475[=5T#;RL+3 .GX?TH .G^?2@#\=?\
M@J6/]+^$(XX?Q,02 2N+4C"D]!DCZ8XK]2\,Y<JS:VBC"E"WFYK4-OD?D3,?
MW,O&0+.^!!).=UK, 2>IVGD#I7ZE'FYX1T48\RT]&&Q_4]^S^"/@Q\-><_\
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MMT#;Y'P#;WEM=%OLUY!/M4;S!.D^0>!OV,<#MS7VT8NTDHN+C:ZMLWHK]K]
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MD>G5YX'R%^WE_P FG_%?_KGX*_\ 5B^$:^GX-_Y*3+?^YC_U%K@?SAK]Q?\
M/\*5^^= /V,_X)7?\B_\9_\ L8O!W_IO\05^4>)?\?*/^O%;_P!.1 _6VOS-
M;( H * "@ I/H!FZI:I>V5Q:2 ,ES;W-LZG&"L\$D3 CT(:ES.G.G):.$HM?
M)W_0$?RA_$+3!HGC_P =:-& $TKQMXHT]548"Q1ZM<3Q\#LL<RI_P"OZ;R^K
M[7 X:I+?$4J-7YJC3C^@;>5CUG]DS56T7]HWX37B,5#>(C8.!QNBO+6Y,@^A
M,</Y"O+XFH>VX>S6G_S[HQJ?^3R_R!:?(_IM1PB>@#L/3&#Q7\Z1EL'Z'XT?
M\%)?CU=7NNV'P(\.WI@TS3K6TUSQZT4IB^TWU\'?1]$F=2,11V*K=RH3@B_M
MR0>,?K/A_DD/9UL[KKWY?N:"?V4G[]5?XG>"?>##;Y'Y18+$ *[-N($2*2Y)
M<)$ @Y8,Q5(\=3R/O<_I\E"$;N5E&*L^RBM9>O1^:8?H?MI^QI^Q3H/AK0M%
M^*7Q8T2'5?&VK0V^K:!X>U*$3VOA'3Y@9-/:X@E4QMKT\!CN968%X!,D659&
M5?QSBWC#$8G%5<LRJHZ>7T%RU*D7;VLVDI+F6JY&K:]PV^1^GD,$: 1JH5$
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MOD.I@?(7[>7_ ":A\5_]WP3_ .K&\(5]1P7_ ,E+EO\ W,?^HM<#^<1?N_\
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MD?S:_ML_\G1?%G_K_P!"_3POHE?T'P<O^,9RKI:-;_U(JBV/$_A7Q\4_AO\
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M["C_ ,^*?_@M?Y!M\BH^J6<TCRS:K:SS%@TDUQJ$#SNRJJ L[RDL0B*N<]%
M[5I%<D5"-&<815DE!I)=K6#8]S_9@L;SQ'\?OA-9>'X?[7NH/&.GZG=0Z>Z7
M36NEV$Q:[O;DVS.;.SB5AOFDVIG(+;@P'D<05*6&R/-%5BZ%%49>SE4ER2<I
M4X.48)M-QN[));!^A_40_P#J?P';'?CBOYQBTWIM;2ZMI=VT\@V^1_-K^VSQ
M^U'\5_\ L(:&/R\+:)7] <&O_C&LK\HUO_4BJ'Z'BGPI_P"2I?#;V\=^'/TO
MTKULUTRW'_\ 8/5_]) _JY/RJ>.F2!]":_FEZ-_UT0]EVL?G]_P4?U*:R_9\
MELHF(35/%6@V<R@X#1"ZC)5@.HPW2OM^ **EGL);>RPTY+Y)VL'Z'X%*, <Y
MVDJN>=O8X].!7[:DHK3W1?H?N-_P3#T:WM/@[XHUI0#<ZSXZU=)),=8M*;^S
MHT!_N8M 0*_&O$6M*6;T(?9I8>$8+I%);)=$"T^1^F?3\/Z5\%MY!M\C\]_V
MK];N+OQKI.@Y/V/1])2]5 2 ;V])0OM_OK;NO/M7W_"E"-'!5L4DN:K5Y7WY
M5%*S\M#^7O&O,JM7B/+,JBY>RP^&C-*[Y?:SFY+3;9I'S;;@;01C^'\,*,_K
M73BVTDKZ66G1'YWA'[T4F^6"7+Y-I.5O^WKFS!CY,]!V/L./RKPL4VNNR/I,
M.]8OJK69TFE:A?:7>0W^FW<]A?08DCNK9VCF0D8;YD.=K*2"#P02#Q7S^(6_
M2Q]+@\17PE2E6PU=X:K3U4U)1MT:NVE[RT:ZIV/?](_:&\86T"VU]I^G:I*B
MJ$N&9[>215& 9%B3:S$#G:2WH,UY%7$2I;*[70_1<%QMF3I\M:G2K12Y8S?N
M*]K)R=N5J^]W9F#XB^+/B[Q9 ]G-<QV&GS926UTW>BRJ>"D\X59,?6O$QN-Q
M$H\D6X6[:&F(X@S'&PY.>%-=J7O?^DW.'@"H%0 *%&T <  #H*^2Q.J=^AA0
M2C&--*T(OW8]%Z+H7HL# P!C'MC%?/8B$5S:)'K492<DVVR['RZ9 P?W>#T9
M6ZJ1_=+5X.)?(]M(M67;76QZ=/\ (^V?AE?2WW@[2)9B6EB@^S,Q.2_V?$:L
M2>N0*_:^#\1/$</Y;.;<I*E&[;N]CZK"MNA3N[V1WK*N.0.P&?8C _,"OI9>
MZFUHTFE\]%^+-UIY6/Y??VG-$M?#GQ_^*VDV*>79P>,M4N(HE&W_ (_9)YPN
MT?P84\?2OZ)X=JO$9%E=3X90HTG%]5:-G;YV?R#;Y&1\ M2_L;XZ?!C4MYBC
MMOBAX.BD(.T^3?ZM;:=(I/\ =,=VRD>A(KISZFJN39I"2YE]4KZ/^Y2FXZ?W
M6DUV:#]#^I:(J4&S@'!&.,YP<_J*_FY+EYH_R[!L?B]_P5('_%8_"7_L!>(_
MTNM/'\J_6/#7_=,V\I4ORD&Q^4LW$4O_ %Z7OZ6DV*_3MJD;:63_ "#;RL?U
M/?L^\?!CX:>WA#2/PQ!7\WYUIFV/Z6K3_,-K=#V.O+ *3T7:S7YH#\6_^"I7
M'B_X1]L:)XL]ND^B5^M^&R_V7-?\=#\J@;'Y4%O+@D< $QQ2N,],HA89_$5^
MEI*Z5M+K0#^FG]DSPM;^#_V?_AII,$7DNWA^#4+@$;6>YOF>65SZY'E<^PK^
M<>)<1+$9]F-63<E*IR1;Z*.Z7;1:^@+3Y'TET]L?AC%>1M\@"@!K<#Z?IR*-
MOD'Z'Y?_ /!47_DEWPX_V?B6H'MCPIXC(Q^-?HGANO\ A5QOEA'_ .GJ*_4/
MT/Q%7K_P,?IFOV#:"Z7N_FFE^6@;']%G[ G_ ";+X%_ZZZT?Q%^1G\N*_!.-
M].),8^MH_P#I,07Y'VA7RP!0 4 % 'R'^WC_ ,FH?%?V3P3^GQ%\(U]1P7_R
M4N6_]S'_ *BUP/YPUX7\%_0#'\S7[Y%V7H&Q^Q?_  2N_P"1?^,__8Q>#OTT
M_P 05^3^)?\ O&4/_IQ6_P#3D0V/UMK\S0!0 4 % #'.Q<]-N.V<=AP*F4E!
M)O1)Z@ON/S<_X*-?&F#P=\,;'X9:7>1KXE^(\D@N[>*53<6?AC3I%^V7LR [
MHXI[[[/%"Y&'-O<J.8V ^ZX#R:>-Q]7,:B:PV72BHRV4JU2+Y(+^9J";E;X7
M:^Z#;R/PK"Y0* /D4(H^Z#@8Z>G%?MJ>FNR2O\E;\@V^1^L__!+SX=2SWWQ
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MOZ X-_Y)G+/2M_ZD51'BOPHX^*?PW'8>.O#GZ7L9KU<U_P"1=CUVP]7_ -)
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M1]GU\N 4 % !0!\A_MX\?LH?%?\ W/!7_JQ?"-?4<&+_ (R7+>G^\?\ J+7
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M_$_@_3#I_B73+--UYKGA2"6>[BG@A0;[NZTVXN;Q@BAG,=X<#"''Z!P)G]/
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MUM+2@Y)KS3MYAM\A"JLVX!5/ W[GB.5  ^9<'/ ]O0D5$E!?#!I=Y6;^>O\
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M!4L-+MH0-N=N"JYXR>_>O&KXS'XEOZQC:M:/\LI-KSOKJ&QV:1B/&#T & ,
M8]!V^E<T81A\*Y?);?<'Z$E4 4 % !0 4 ,9 ^,@$#H",X(Z=ZB<;K1\K6SW
M7W:?F&WR/,_B!\&OAI\4K,V7CSPAHGB&/8Z))>V4+7$._ WPSXWQN !SD]!Z
M5WX#,LRRV<*F$QU6C*'2,FH.VUX7L[>H;>5CXJ\7_P#!,KX-:Q*\WA'7->\%
M&3[T*"?6;4?* !' =3L@B @X4'OBOL\/XAYO&WUVE3Q?*K)QM1EY7:A4O^H;
M?(\SB_X)3Z4LH,WQLU"2!3_JH_ SP2;?[OGCQRW..^S\*]!^),[6_LA:=\5^
MGU8-OD>W^!_^"</P"\,^7/XCMM1\<7J>62VJRRP:<QCZ$Z8UU<KSCD>;7BXS
MCK.:[?U7V>!@]E"*<E_V_:/Y!M\C[3\+^!/"7@C3(='\(>'](\.Z9 ,16>F6
M,-M"@/4!8P#^9-?'8K$8O&U)5<5B9UZLOBE-N5_1-Z!^AUJC: /[H X&.@QT
M[5DDHI):**LOD M,"*2+?CG&."",@@=B,BH<$Y7E[T4K*/9_S>ORZ!M\CQ'X
MD_LV_!;XLRO=>.? FBZKJ#+L.IBUCM]2"@!1_I<:[B0 .3S7LY=GV<Y2O9X'
M,:M"C_(F[?/75>5@V^1XA9?\$\?V8[+4[?45\)7UREK+',FG7NJS7.GNT;!E
M6>V9 LL61]P\8XKUZO''$=6G*G+%02E%Q<O9+GU5K\UP_0^U[6RM[*&"VM8D
M@MK6*&"W@B4)'##!&L,42*.%18D5  !@*!VKY&SNFY7=VY-[N3=V_*[U#]"W
M3_ -OD5Q  3N;*Y)"@;1S_>Y.YO?BH4$DENH[::KYAM\CP_XD?LT?!;XL!I/
M&O@;1M0OV&W^UH+6*TU50!@;;R)=P8>N#7M9=GN;94U]1QU2A!?8YFXV[68;
M'QMXE_X)=_#6^N))?"GCK7O"L#,Q2UN-/FUY8P3D*';7[+(7_=%?64/$3,*:
M2K8.E7MOJH7_ /*<@V^1RUI_P2JT.*>.2\^,VHW<:D;HH_!3VA=1U D'C:38
MQ_O;3CTKHEXCXA+]WE=.F^_M4_\ W"@V^1]#^!O^"?'[.O@^2WN]1\.3>,M1
MMV#_ &CQ+/)>VS2#^+[#-)(J\]!YAQ7A8[C7/,6I0A6CAJ<M&H17-;_$K?D&
MWR/LO2-!TK0+*'3M&L++2["VC6&"SL;6*VMX8D&$1(XP -H &?:ODZDZM6;G
M5JRG*6[DVW^+#;RL:P7 VY/'?H1]/2LTN6*5]NH;?(:8EVA1\H7IMX(^AI3A
MSVU<7'J@V\K'D'Q&^ /PC^*\+1^.?!&B:S,4*1W\EG%'J5OG@-;WBKOC<=CS
M7IX'-LTRV2>$Q]6@HV]V+:B[=)*]FNX?A8^+_%O_  3"^$^J2._A#Q9X@\'H
MS,RPSPS^((D!/"(C:S8851P![5]AAO$+,J22Q&%I8CE2UNH;?]N3#;Y'"6__
M  2ITB.96N?C7J,\*L"T47@A[9RH/*B8>.'VG'?:?I79_P 1(KI/ERFE%]'[
M5?E[!!^A[UX)_P""=7[/?A>2&[UO2[[QM?0-&^[7KB633W=,$[M-DFF7:6&=
MOF5X>-XWSW%:4:_U&#33]C[M3T51)65MURAM\C[0T'PEX=\+:=#I'AO1M,T3
M3+>-8X;+3K**V@C5<8 6+'  Q@YKY#$U,3C*CJ8C$RJM_P UW*_=R;U^X>WR
M-]H@5*YP.F .-O0J1GTJ;6BHK1)6_3Y"_0\,^)7[,_P5^+4GVCQQX&TC4[\!
M575([>.VU,!""@^UQ)N." 1D'D5ZV6YYFV4Q]E@L9*%"Z;IOWHW6SU8SP:T_
MX)R_LTVNIP7[Z#K%W;P2QS-I=WJ\\MA<&)P\<5Q"PVRV^Y1NB(PPXS7NRXZS
M]PY%5I1M]I4ES?\ @5Q;?(^X]/TVSTNTM[&Q@CM;2T@BM;6WA01Q06\"A(HD
M0<!550*^-DY2J2JSES5)-MOUW#;Y%DQ C#8;G/*\<]01FL_9M.ZDTULU_P .
M&WR/%_B#^SG\&/B@LG_":> /#^JW+8Q?FPABU",K]TQ74:[D89/.#UKU\#G6
M:X"WL,=52B[J+D^7_P !#;RL>!2_\$Z?V8I+E9T\+ZG BL2;>'6)TA8'AD9
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ML_P8;?(^JK>TCM56.(*B(JQQHB!$CC4*JHJ@X"A5  [5\PH6<G)\SD[MOO\
MB&WR+73\/Z5>WR * "@#D?&W@7PI\1- N_"_C/1+#Q!H-Z!]HTW48$N+=W4$
M1RA&'RS1DDJXY!K?"8O&8#$TL5@<5/"UJ5]8.W,G:Z>J[(-OD?-=O^P;^RY;
M2PRK\,-)<P2I*J2C?$S1L659(RN&CW'E3UP/2O?GQAQ%)5%_:4[RT3>O+I;1
M77Z#3MT/JO1]$T[0;&STK2+6WL-,TZWBM;&PM(5A@M8(598XHD4X6)5;A0.N
M3WKYB7/4G*I5FZE24G.4GNYM6<MW;30+_@:],04 ?''A?XU?M<:IXE\.Z7XD
M_8F_X13P[J.N:38:_P"*/^&D?AGKG_"-:+=W]O;ZKK_]B6&E)<ZQ_9]C)/=_
M8;9UEN/LWDQL'D4C]HS3@CP?P>69CBLL\<?[6S+"X7$5<)@?]3<[POUS$TZ4
MYT,)]9JUW2PWUBK&%'V]1.G1Y_:33C%H\Z&)S"4X1GEOLX2DE*7UBF^5-V<N
05*[Y5K9:NUC['K\7/1/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139947449196000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 14, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000872912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 14,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DELCATH SYSTEMS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1245881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">566 Queensbury Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Queensbury<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">12804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">489-2100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DCTH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MZ.KBO;QH&)7D[\)+9>#-.K_<" YY9CO ]RNES$?#OEZ7OXX,_@=02P,$%
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ XH-S6"0>FZ*M    ^ $  !H
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M_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%
M  @ XH-S6 =!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " #B@W-80:]6=NX    K @  $0
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M<R\N<F5L<U!+ 0(4 Q0    ( .*#<U@<.&7J/P$  #P"   /
M  "  680  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #B@W-8)!Z;HJT
M  #X 0  &@              @ '2$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " #B@W-899!YDAD!  #/ P  $P
M@ &W$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   !%
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d784354d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName -  d784354d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d784354d8k.htm">d784354d8k.htm</File>
    <File>dcth-20240314.xsd</File>
    <File>dcth-20240314_lab.xml</File>
    <File>dcth-20240314_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d784354d8k.htm": {
   "nsprefix": "dcth",
   "nsuri": "http://www.delcath.com/20240314",
   "dts": {
    "inline": {
     "local": [
      "d784354d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "dcth-20240314.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "dcth-20240314_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dcth-20240314_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-03-14_to_2024-03-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d784354d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-03-14_to_2024-03-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d784354d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.delcath.com//20240314/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-24-071355-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-071355-xbrl.zip
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MG47!I[+PC9<.KT..YOGFBX9J-H5'V^J5EG"_4FDEVR-)N84)76\N.]]CX >
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M4O^NJRI@6!G;]8K2GH4Q<1J[-Q1FLZU8N,*#[3!90NN.].)CP9MEQI6G7O-
MH]/,"V7M2EA'>2$R;Y3Z*NWHA)/DK9@XY%JI>/1?\ _$J#BD[$&_D; VX6U!
M!)G#<DQ-I)RH(I IBH6O5T=(ATO!9W('<I;TW&$&C&C7]\CGW(5Z!SA&*MJ
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M#!$M?_7W&!WW;W '*2+,IX+,Z0>-A9DVX20,7+!X>&8(7**5_V-9*:18YB/
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M2)@U%'Z\)A2^VW7<&LMT9)G^L\GO2\E>F%*,A'&&I+O#!_?(>LJ0G@86#,T
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MN.;2('T<?[.%)[*]1:AY3C:A)-HX-*LJU*8,>!!<J"S)0[C)#3:=[6Q!VSI
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MB?B.UBC/0^JL0Q3R8-SB^*F#/K$RZX0U$448&D+#$Q$IO$VE.**Q#P6I0,=
M5ZC#;J,%_[UD?>ED_:4+ & F"NZ+?EG/*$HK[.&8-D1\B]1DGE>HB>@C)+=.
M]IPX+D7QI)4"BQ;O_$$>"+T5?*@BK&OCP'#;[3Z4$" +"++?'T2*32'04_S6
MT%&;S6?O_P]R%H4'W#WDUB4"66WRU1C-/ 3]>O(.3 5TH:\.V1GJ*G?5V+&
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M'J?Q>R3RDC0J4MATF(D9)9K%9IB&F8@AE4S,4Y#@3#4_56OHEIA"SP*02)C
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M4Y' F:-=H,&2,Y,B.(856O+M:7F@(2Z8P0'$*/%>*M\QET:Z^>>QB#%ID:K
MR K8IEYD$\*H5W7T^DET'*+:TKJ!#R:'!T>'8$,1 ]^==U,.9C4=A &L^-@E
M=.HZXM( ';/.4>7?V/HCMGN/B3<2__4D)+/ (O>-L\TFM@[0.)-2K8K/<%G_
M.(^]\Q_/]T ONP817Z2YKW,(<HTPN>Y.DG)P1,GAF04M=0'/MAMU+A<,-C]=
MUB5G>RH-M4UGHXKFZ@;SC1MF07_S[::6K"\F^YH6H+/KAS1-2W_*:3UP=1O6
MB<&5E*BOLSXK6S2C /N^'UQQ"!MHOBQ%X;+1?^=17IB\@OZ*#A8($3-P_ML+
MC=;F?M12V_V[NF<9E&$>U><V1 QC7=RZ8%^MFN8L60T/"P%[#BS<;^#8V\CO
M\.F,2#OAN9Q^[=/S4T-8E#5-)BH,S,RZ\LM**_M!O4O#(MDX<IO=3EOY$W;C
M?OW9C;OF;#Y]C[/YY.%C[\7MTC_^ZND?.WA]XU8U^-DID3.V33[C.J!38K?1
M*C;^.<G7,+DHAF[2EJ8:+"P:'O+0S8-/3<&XJL"\.%B6,Z%A(YI75Q1R(DXZ
M1\K*1X5.3HN\6&R]CY0ZL]6BHJZFV.%W.Y&GGOWSM:&K>IX<J_W&2W/502"+
MVRPK3=20[2F)]B>3)0/#-7MV(O11<U0K[F"K3I"MWU7<EG+E!$EQVK?7V)1
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MT61K6U'CWC#4+MS]+J<<9:CA].F+#?9<!BA$QUX1Z]/#0FC=T#5/]JR#L;$
M3/5XBS&BZ:!X5N4X'C@RABZ!WBM^Y%)N$SS='3XH&3X7.J.[44FP%:;0@4&]
MZXA9.^-AJU>"Y!6Y5U!BV7&9Q.@^.48E\1!:PI!G^D.B@J7D)&'*-TWP#>?\
M8*]\A3J[B%BYU7'7Y.4,ZUOHO>6"\X1$T54/E-Z^>-(66KD4&=5;Q%B&LJ9Z
M_7O8I!/WU)$YXCO7:!*A>@*/L>/' 7$U*S>F-'&5 VN4^^RG\OG[ISD5WL.
M[G6]!#M.E^1J!3H(5>]F9%L?*0#%49>-0VR%/&S#AS4B4T.VTD:O3/Y)XW_"
M4-K4T,6C(>,%!N6%.(F1#D",</09#9*?_9F9I/LPC@&A-.6UJQ9GV:41OV:(
M*\+3LUXV-!\D''83KI64T?/2)44,(BE5@V?V <,=$+J$>/=KH3"KYZ++!K3
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MHP;_N#G47YW]"3TNX1I'A[NP(^#@9BL.X:*:+LGX1/G=:)J5,]<-?RK]PA=
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MMJ[H45+$XJ+YY;T0C%I,;QVFC"(QOA:.%N77+$<^(,*89CDS!O.)B^<I-2"
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MV^!MAV7775"Z+.P:4X#&$_HL:EO,A76-#DS$2" 1;;CY8P@;,=JJ5JKUW1;
M;?(7^.,8%B=I@-:P;!?I8R\QDM)6W_"3M3PX*EMI*Y$7*W/E!H^",?=6YY(E
M$M8IM4:-94HAJ=;,)>N8G9?/4\Y3D[I#/%J+"*J&+V7MA$C$ )RY0_!62Z$#
M%[NV&R"T1P"S"$^_$%Y@$PW4&<=&SV9>R8HZ&JEU5L_KU$$P+740Y$5^E]5+
MATF@"U41Q] P:)=<QU!<L#VHV6*@(QME2<GI\B:V:H+5TQD56_G04'+:JGA0
M\0J_ZJ9#<R2N\64(@NHTI0]#M3@,;I?I]/^OAP7=W)"@=W.Z$EOU9-&J5]1M
M  8%B"=,4S!61O2PGO_ KYZMC:M?%_?U)5,P%_!0HUJZ:IM3&$_"#^CL?WCK
M[/]&)5"'XTA=A9#L[BEQ\4K^:@:0(M\Q)P)4$>Z.N?CN#16GE\/?D-T292/T
M:=U K^D!9E;=*WQNRV:=<ZI[%B$WAR"GN@*)H#Q]3PU6#,%#_>GN5K6Y$<;R
M,=I(X\+#RAOZN;\_W2E%ZU&#1]9]UBS\QU3ZKDAV8=$A3#X2Y^I)R;O63UQ6
MC\J,*8OYZ5FT=9YMJV:7Q)CQQ#.C8L$YPNCSH4D3J>85.EYHFG,'":SU9YMM
M0<H9,&50$TCZ:$,3TQRWNU60S0VK@VR1:J;+/K#C7+:]M;\-KP*S*%[!,QAY
MCD')S4'B$UCA;*Q !T2W9)X/YU#DVP;6P)74,^)BV,KOG$'3CEN8A9!O)D$S
MJ.D."2NVF(W48?'T:E19ETMPZZ5,]T)=?:.LB:?#CP3!@^(UQ#Q[X_A+O(1>
MD\[;G[%**B*.2[G%C;&M9JQVN[^\3S2K5V9!EU2:N_95'&BU257G6!I#YYJG
MM4?3NDTX33Q8HD$\7:H>TA'U]D5#!Z<4G2*GRW%D^#29@ZI#CJUQO].E?WT^
M>=&K',M5^FRL>85<<<+41HVM:R71Y19"=4*,S#T3:U.8B[D?JX.56*D@)2W+
MLW_%G.:>&5;MY?LF'9F,T8W%YISY%RM]W0;;.7?:!Q4V+_.P-UKMG(B4:,FN
M%CJ-,#=, 7:4B(H^Y>0H,J@:W_- _8NE%.QD8C%B_X0OJA&C^\2AK<!/J/ W
M5\$3MS,NI]MM3&-?*"-4,&S'"BX*3:)94E6@(]*D"7\5MWB:?!8&@^@C.<)'
M:#CAE1I*@,6G0:SI-Y5UX&264!T*,&7;][VR=6F\Z,_*81))8&H$?%!6HDDM
MQ](T^B)#?N+EJ(2A&)NOY[+'C5D+R+V-^%2%F-0-N=JW#[Z<-TVJ(J]'5::*
M.\0(YULN*U7XR^RNEQ6/$UXN]NX@"5V;"F?_D092'#TVTL?KN>6FE&%REFI"
MJE6X?(*9KN;N#+,2=@<#[_ &\7#9*,."J\F07%C= -8W21-&:2-Q<^ZS2V#K
MZ@;@)4;%6UT'P^@LC0#QG(,Z,[-%'$T;W<.7\4/[DRQ%KZ^X)NV6L?FOCMEK
M%*&@9AD(G:]@5M,"Y1<#AL;R\0H5K!=5(!H/)]*YY-: <L51F-5NUBJ=5QO)
M#59%$VW,0#$V?4%+/#_Q%5T_%'\,^GX,8VZZ?M9C94CZV6^K8^XEYT4V\D5_
M05C&B*EAVH7 OP<V/PJI=E0F%\E$='0'HRP"'M8X(Y'R]<*^4;?'9- O1+>6
M2-'ME<7HYD:W')5;V>J7B&^9%M/T&@#8KY)9]":8/^ P)L%&*T_3V!5AHQ6#
M9@]0.E[L83%K).GWQ%3HH9;[60=L@E*>P%\PKC>?I *?[V36U9(K;%7@ESJ5
M-@C6VE.6GD/G-[C]5E5;\DN=(L))%*I=APNJLE[2E3_AK.$F J>QH=Q^!"/X
M?CZCY9' U*;""77^HZF]/7C]Z_ZGJ%I4^-@6D3DV)JVJHC1GM^T5/+GUP#;/
MSA85]05%4OEQ<YX?W;I!KYOUG J@R%<@[B+5#18FH=!"Q+'/B>C3=\BWF4XX
MD0O>J9'L*DD&,"ZW+)R=9]&8B$,M3X5NPL4V9KI"QED<"0JW*M0]S<Z5/29Z
M3V?'EOL6?/&F)<X9'_M'XV]CLV5)5KH"AHHO!29H ]0P&(MUTKZ&13%+2P_X
M:L7#]G,OR^7*1.\/MI<XG14&E_)F;VXT*JI2C<H!OW@Y 7/J^/,"RW,<**K6
M2"J=8?8;6/>(/8.REA$$7>JO<N/;-A2Z[M\D.-"]N<SF$"GC#FWK2N?^@(C@
M!14@Z/B:^!T&A[7X;LA!HV;N&7XI$TDSLFD">?XNK7R3>Q)4EQ<2!%JR";'"
MO6:$E<E"UCV85QEM24#/1"\D)D/57BI^9=Y&&$DVI-JPU;0Y72=?O)9!*XUA
M7ER81G$&',8F?J/MGI:FC]8,749N'=R&3(^T'OZ4V>B<[_2W[*?!.W2*%::N
M)4,T;Q-I=8@^+(J 80(.TP6EKH)5#J3#CLXA=JBG6Z)QLO >],9WY!U2Y!LA
M0D^%NJ+/];LM)>F9H =W!1+PFKBA%7N]V\G?TRJQC$U^@$4(ASL]24\1)XF5
M9WO_1$KWKM!<23C,PC@F6$;ZL4JV]).I8U[Z4-#Q(4>Y'HKZ4ZQK:27G>W^T
M_[.W+=I] JQ<(2_'"07?:U4GGY&FLARI@I.@-1,PQ04NQQ4&J.""6H\<]7;#
MBFS!-( MY1<WLC0Q!QO=B"Z%TO!1;+N0 I?!4LB1PR<U HIV(7;9:HV@EHJV
MJ(3[GIC,LH".IUF99/2N(H#+^W65J:EZL<4N"T^5U1O.;T>Q3MA$W)*LZME+
M'X-0RUCL=2TQ-XYX#V9<-2:ARIVO<;U>QO%*F/0W[WEM56U[<4JEY#537Y<%
MQ)L0QG@OHV10G*>-$#C!KJKXR"HQ<!-_5H_[87&5?F'6P$S;#"QCMCH8G^CH
M;!^^7)K3G;2:2CB0;X$0J[GT8_&R&2F4;#U<H4J  68WUUD]8;*QW7UQ2@0R
MH>$"&AO^YW8SVV!EQS+>/1VGZ$83[JD:UWA-0OD>_D  :)C"J2;)C;2F0E)U
MHD?WHDMAR#!TC&A-7PD;LR:XNL_2Y,ONWYQDR?*&.9S_R%G64I,OSE/LPVAU
M HOKZ&(1JW7YK1MYD$K"A!OM<*N17_8ZLYUCQ^*;'1,\\47*2E#*,4]$KWHH
M6SN48]P]&12\/F)_@PN:[(EL'$L^&8=?5\I0,S=[5*25 M9C+1&+G3(^%5P_
M5\7 B'8'37:U[7-@UZWGF)2^?22"$'ZEN%+;9N< 8R.#M2N/#@D!99/"FTQ,
MNV'%\L)F94/Q#Q7?+RNY_W'=H[_<ND>OFU=.F%=JR6DL&2QXXDB+Y[/JKYQB
M.P^#-4[92ZSROC1%= #7'LQ$YM+%19ZV('@X%6_<VX:#AD+]'QCBC"(C+@>;
M- [2=LZ+VKA3[<T]E_+V8A(5)A.,I[H3O78P:BS>JK:C!1']YKG!))JF:<T%
MI:'JZ6"$_1(7NBHF:/0/4FGTYKQI#CU2SDEJ3E5$VKCET) /072V:L')LHUI
ME("N@AL!3+!,'2R/P68T6!.UAX <%?E$*6EU,9FD(^N8/CBWA<U(C4X3(INV
MN7(;EP*K2KU3-#?6&P.CQQH10V\.J(*>UT/MQYHTFBG?TM]),XFHD)DM'-IH
MC5.LJV4Y>0(O%&,J>WW3G%78TVNZI>!@$I$<BI;?[+1I.JD8/E&YC%NI&Z0,
M<\&T47_T!0CV!=KB4UN>7^?WOR.7K3BO\%P%.:['</>Z>IB](YN@PZA1Z,AD
M?.(VD]<ZT%9.X;^0Z8W!6@Y*X26BR55U(85U(SC"7.LS#QX\H_R#[C([2B@3
MMR!WV2/'N&1*D*^-,[@4JJMAD<9SL+FAO/=*&3X%F\N4TFR+(VY&>V!A9E6,
MV#+JQO%W%_"%*H:J(B* ]<3/ &9PT4H;6-*9U?6V?M:L7E?22U%LK,80MZ%A
M%A<Y^_NZ4$"MUCM'YYL!(C%IMUO[%D#6?.5DHY^TR:UBRGEJ4HYJRO'EEH6Z
M8IXWG#$8=1?OL>KEN.+6JL1K4PLJKEC"3)7>XYK+B)_"I[A*(O@@%Q+L1!!3
M'?7,)K1,BZJF5%4RC_,YI^?^:P[V;UJ2288K:A()M^*Q>K*F,R^3D"LB&QFP
M8?AZG9CM7HW(=NIVAO3P=M:%T$<@AJ<Q)EH=)XEP5V"VXH%BYEIYX4/Q]] P
MBL.&F.@:\&5 9#T(0]\<?,$LJ;4!W^QC!5$J1E@J<T$[.1LI[RQL.)&">,XI
MD.N=8-Q(&V@2GE5!!D69IRVRY*H%]E@6=0]G(5E PFN56 O[O]K+TRBM#L"
M.T)$U"LE-T4[)L<Y[(UPV73$\M4<1&)04A7)Z'Z_QN9&>Y9AO;,#<45'9MJ
M*S)+*FH)MJ,3B/,@?W!5*!T_;;BAW9OP'(TJ_3XI/Z>U0TBH!=S=63J90(%.
M,M-E%-43E<UK>%2@9:V2Q>PJ[XO+*PY&&A1/W"=)Y9I9UOO9GAS83 .@2B=Y
MS%DU.^^B<[[)'^T4O=A]Y=4:+ F+;W.E"Y94<1C3DM*R)6B:L[_V(I2XA+Y1
M8=@I8IJ""$6L'6D_FWI!U\T-,XZNV;CT]JFZAH8P!XH05W2&SG1IWN?+SPI=
M6!4E[HN98Y_T4\:#%](E/7P4*QJ[^V5Y6]1Z(I#U1N.6J^;3J2?@2 LW'J]F
M,-)GK-06Q]0'=73<X'+_RI9<B&&0408)L CTBFI6/R_+%KK&=<T7D27Z:8^"
M*,DD*;/ ?K>PIW"D8H%'(S()*762GK+R)"R/,'#G0IRLOM$K;325M:T$9N4T
MP* 4[-T:9%0*(*JK$5XA>1;ND]0HF[JSBO)&'BX##6R=,'Y<%I\YW\J8KT.E
MBLK*+:Z@S61KY!J8A!DNU:&O3MQI1Z^-BBE^#]IXVCE3SX*<K:HMIQ*-[\?U
ML#Z^];!>LR+\T"K"A_"2:6Z%W?6HP%=!2VS/J<'6>8JMJ&K<Z@5*[IQF68^?
M6)O)2&S38<(&8N:74RJ:]J'K.-F5N&"LX?>F*7J/T=X&HS&GOR6G?#V9'6C1
M;S^Z."LX=Y:-R;0;5X3"RV@,S)!=^BVQDV@&%N9I:O(T5,=R8<W6H\0GAM'6
M2=._O1VCG8D(?.P8'YUG5='B]5N^?\[(7E;]HO$\'W*Y+$(Y 3L]Q[ NJ,3%
M1.KGI!@ ]]BV):88>!4X.5 201LU+E1ZS"^FI8^V;=D%<[IIS/^2H7"/Q6_>
MSHS:8B\2NQ84S* 7O]Y]V($?4S3[N=\S#VHGQK85;/V4H[.%VG3T3<X!R/R;
M'(0 )=*FD^5EJD<,[.A\,B'_9""OKMDPP\ DP3Z@.ZWVTEXG145*['"29%/<
M5_;YQU8!)1\8RT&E_K 6V-1_5.0] 8X&YO&B8F./!.NVKY-L#3$N0.%@]-=K
M"+UW-*M68Y'$*3((U)]51&SS6@QYC?EDX1%4<2CKC^DI.8B7YRPYD*>,L!.Z
MT0 6@5POXAJ<HJJ^D92+944$[LE9*0UYRX5Z%=6H]6\ D98NH)>5N\_:*PXF
M8;G2XDLD82&ML,Z=!!.8.DH2OC9S:[N1N44E?'N* LZSPCCBW%:X#]O5]8$L
MC[CMN-;UWEHKYD8U99<SL%8@RQT*><--U8PSAOJ@A/5@1LNA@%SC<W)"6[</
M<1R^%GZ_S=*2#+NLN!.M1.G()QX&*M-2PBOG4EWI/%O %RS )D! 4VT;3$%P
M_#B_SV']"/MSO>+\J4S(WF]&!\M LU9*;F'8$D;]$M"ONLQ@^Y;G?%R0^<,]
M!@V7D^E3JX+SM-FDO'^MO>A) 6#;%?G*5E9+=R<7A)*HG[-P*"IA9VVQ3O=)
MK907L1\CJPQ P[9?--NZ_"V\!MO,EZWPQ2SU4WM:^9'DF+F+/HW8YA0VME%&
MFM<4OHXQLN9:_=DP,\7P;;Q#%T[9DDA;(Y8H%-Y&4,!2L=D\G4-4+9U%I"=A
M3KV=#>%#6RDPD,:Z\=O]T;FI4[=.#-3,O*U\1$5;+:V?E^FC0]G EP%HD=IV
M\=8@?@?Q.&S_$T8XL2**5) B&$RYI!,&!W'8S HM.;D YK03'5,)B-@CM>LK
M3FT*3<,DV.\A^_.D>P9SK8FI#">?EX;2-DTS\01!6J3PTK'5YHSQ@T3""2EL
MC$A.;7ENNE";"+49HZ=0S=6*]Z09-P[V;'L'#?NUX>R&+4Z9/UN;&JI9K$WL
M6L6U20:#_\\BR^O)(F151M:H]..J6,FG+ )G)H14_Q[K1M/45A@_?37#!@=<
MQ;*)K6G3-WUTG%O#1<B.W.X-\Z"Z)OL Z/:=V 6>RNU+W;;^V5(-GD;7I7XC
MD-5J"GC\@^K95G5NJ-F;&]^QGNTZAE]"YU2JIB8!IVA2IEWS_#W=SL.1[U:L
M&BJFKV<Y^*8E@*V!&AA/V[GTVGNT5%.7:V*D^E'KT98S7PHT;U"5OG/=5N-O
MAC34Z#H4U"NHS5U1#!>CHSO>R*0=8"Y52J"-6:[:(@I2$C#N!.&;^7.YAS-6
MG:IH*T]K$Z2S#I-0T\J 1H4K(G>.QZ?:13 /K>QQDZ!,=TG[U,/@CCO=E?+N
M-!/#+I8#VQ?:*$9]5WQ;VH*?MS-NYE+DN H.@H9MTX\U;K  &Y0X^;IHJ&T&
MZ<Z:US]NA.?);83G&R$MPU]?2<L=H,BFGJM '5G1/6R90BYMB!+L:LH08MLI
M]5VSHICJTC9GS[@$\RW@)-IG>JC,D(])62]:[E,B^]9CIANQL?:4)2@S(041
M].2IFD>&F7FXCF@+GPQ-9$&*:6 F:)\Y] ?#A-H_DYE1JB^9OZ2RH,Y58<D@
M\U&PKG/C',*"'PV2E(K:;%1,DX6ALF:XS"A!S=L*[/86F3FJVKZD*]NL*\X.
M%DISKFU,!]N G>FG/1.8XBG:DQJ9S@% E(S4U[6? 4<B$*'R]+=[#;>]BUO<
M:'NRV YYX3*O12+%3W#A'#\T, A#;$3#!S*=I?1C#QY"JA=]-$&!BE#)P* "
MI)PL,<;&-I1"BFK*ME*US(8J4C*ZN)B<4H_." M_ ND,TRZ"7$=28]YY8]OW
M@JD=%!$"BG#]PS0.A_;.Y"*\2R"C;(:_L#B.#4H=<#?&CMP^B5;Q8/;X#5Z=
M2UCI8$"(U"A]PN?4$?2I"]]T4#)I@)SPYGN441/A@V].-'81@>7L!LDF'3FF
MB&98@.NH*NG&ILI1K,!Q.C8E?&8,3GA?K0,Q*T:VS[H8I,U)-;H+9MA=)1FY
MWVT;12H"PCT30Z2;#;;WCMFXZE<7YJ.MOF@#R["HU;@UDQ$7<)*QL+7HH, !
M)MGGE"TK CPU&7$$F&U&)VN5<)L$!J5KBT/+V=S@[[9L3Y<AY;MGG=3K@0($
MJ*KI*P8.F4ZHY4K/C6W?G:Y][Z5E9)BKB$_3_WQL]T2%<H-7'LRA:<$U_HQ'
MWUI"#Q\(SUG\TKV+&;#5I7+%JK2N)\Z)%"!^]O%*@04Z<5 &2K$&N1DJC64C
M.$/>D/-<D2R^Y2R="&[')%E@;Y:CHG/>+E60+;R.=K;!"Q,;!W5XI0;?5"U6
M5?Q83WE0DR" A808 !7+D5=52@[L.,(5I$&O+<,F"&D$\>SCZNQ6Q!0#9R;G
MDF<@][T4MY:(=+C]M>JAH5:%!B'53UV*CY+VN@:9O2H<H<<+.^Y9F(\J?M[[
M@D;-3U\6J IX</R<(71$K!*?&+7.A5PY4H'&H,Y(T81$7;>[ &X[GD"NC"XQ
MT? Z&S\\W)=F,:NY1Z((&R;&+W823//+MLZ]U"(JTVQ*Z=Q=S-;A^!<V$A96
M0K3SW="L"7SA6U3+Q8!*4!F5.NK2J G0\)NHU (XTL!<:3I1&C@$-Y[\.-+6
MNG5P6IN<PYC^E-F:]CUC6PD%M!]N#;9QDW2LEC2LL!*+^?<8NLE2 7&AD%7P
M:1O',F+,Q%MJ:GR?J/-OR<&A69G%'!;_'5TJO+G)@J9J_&J!"V8\WN09+DU9
M7"9N51!222TZ%+?\994 O8FD'$O>9/@Z,,)B4*,-!7^%_..H*^E$6A1@LJ;"
M:N,-PUE?8-:G@+:92L))>HY6++HH:]H+XDO8.(0&8TVCO2!ON]3&AQ=$QR$A
MUQ_06;A[[]9;>(7M?($-LAN,6*.!QW@M4936W,4(G8.Q[6I$80?;S-DT(F["
M^GQ=Y%1'TKHBDAA55+^)I=T0XH(EGU/ZG20]Q#;BR?:E%X;#6 GW\HH[+P_\
M/"3BK4N-+%!)$[57DIHPPK0^Y\4%Y6;'F/Y D7]_"N2-FB$3FY-CDJ">RE)0
M1!$BW5J O-^Q1B]16\4\H9N5BJ[<RAVWS-MI-P[.SY9<-D#"7-9LY3>.;.F(
MN0=HU4RK-2E%MG"E[8D<&%S461<7;GBJ?:\>BPGZ*?>X<,@+.O'%=NQI3R0L
M=MOE.4Y1I)"C)W+5+ *),%1 C5KV&I3]$T?#)O9(CBEK[/.NB27YY[R2!@96
M,F5C)]&S!BI7(&B'4('DX? Y#VSGY@9(MX0ZIKCF3B:9B(C$A7_50S1/"[M%
MX%4M?,\N.1HJ/\ZF0/NH/[!'=<A$A<Z!TS*9G74%4[T]<!YJYF\NT2T<!R16
MO#3:&OT%@ZV;&XUH:Z^LZ!<,VY$.R0+I7B82&PJQ=ISIFFZI"UZQKU+-+3$,
MM_+3CCRFA.Z*S%6L&E^K<V^T+$HK!'&#$'."?7%BE#>%XG6T[OF:(K9'MHCM
M?58-09E.\K287Q.*PQ5+V#ZA(,T,I,0A4Z--'4XB5#>!T)KY^Z6&VS97C>DW
M*XV#C%)R@SGUFQLZ[*5R%IO5V\$693Z)<#)+&L(I)?\/.F4K1-TQ;><GR041
M:#C%7SM^"#J>UF6K=H+ J))8/0P5%<CX-!B2I5^@?: Z66C4%KTG@MS$T%$%
ML%),6S-LS0D_VQ5^!*R,_<139+7,Y8T9S.5(GO+BDDKT<6>U?ZRM7N5>TC#E
MCW+##^/74-.FNKT&93GUG#2;T [ZKE9B>#R_V$5!"0*$@OR46D2?720F(=B%
MV2CZ@4 _(\+>0AK@K1NX'5O391RHRXC0^^EHC9QAN!V96> ,7KY8LY?I-7!,
MTYLN>NT@0GF+7B[HCB5#QFCN3;6+NRY5S&+8Y/[3/6!_Y^8&^=@]SK>D.R9_
M_3DC*(MJ" *PK]PBTJC5L:>C$/XS62VD!HW</C214OLP^I?@M#$8'+>)H'):
MJ6BP<";-U!,N@6BDFS2E0PB66KEE58;@5D+M"JWD9KPYFQ^8CBS8;@I:N8]G
M_2R4W>&0>2QW,!:J4;-B529@<0A6 Y_5,H\AXA3< 9LCE2"P4'2&+'O? 1R+
MIT\=1Q.#K&YENVMP-8](K%5!"#^5I*BT 7@[3X"2I#J;L8:!N3HV49-E2'#?
M++QYU(-NOKDAMY^R4X;6 V*B9@JB5*"574&,.7T?R4C?3I([/CGU:/4NW4PA
M;_IPYY[<;<&6_[BYE+N[M^[1;]0D%%.V78MQ)//?42<R54(G2]2Y1I(?U6XV
M'S;09S'=0_&^"*N&SXH1VUU>OC=5E5/".TV&L>%<>[@1QD.Q[T@56;FK1I;8
MHQH.$_5R&UNW>2KV)JG,$"H8@Y-I@R\9MX&I X,A'M[;V?TIPBZ*E()A:B@Q
M<E3,:PLZT'&EM\8,?XI9\8Q-A8!%QB\GZ'<J\-]9IT9=6ZE;#.HGUJKA7<,-
M5#6!\K/%=B, 2XDU7@J^.1SGPN+C8"%HPU7L7_+S]S+8,<RKL4(005%/08.9
MX31D Z5\5&5>,+QP^^7\.IAHW]LT5!4S7$[^[9):5B3:KG)+L6Z!OCV 0-X/
M'^=_A"DX 3 YIE%N$ZKN1&T:@#C,[MXN2@J1#ZDG;9;Q\3.C^9!SYB)V1%+X
M [^U /P-T[$KCQ%1S4[Q%$#5(]$FQFH75K:90B%%;G0]>RIZ,%_'!^CPM+/8
MVV35>8PY0-_M;^(*)B:I18*8'$5)OU#ET7GJBH3$#N?0C*I4+Z:IMWV^MY:+
M!B<2?;;_2CAIR'\O:T'F7:*=$(OB:J5F47&I6<YR0&98ATI>:&^?K+VG$;<J
M1.]AZ+W\/&XR=).T' @:A,;!G.42E#T[F!F]46J;;E/*E^<,5V2(@$2IQ(\X
MST7E]>._<-YJ<RA90-.<SP(EV<O,->#?:(H8?V+)!/3SK++SJ@M]GBIUM.G^
M68MQ/;8ZPA%9N:(4["O0&C9_'5 ;P</-<PTT*:9%EFJ,ZE(5PC)CL\*HK>AB
MVKK!B4]:4;I0Z[KUM(8[M?MU;'HJ,ZO8KY"+6IW*(Q@#""LH5[@> 9.G)"+\
M.9:J9,P=71S '\'M9L)C184')&5IR]7#=PRIQ<).JV&%>-%@A&A++C1PJVE:
MGJ;EMG9C(D%T=F-8FH))V1R-LOO+*5=^A3L!Z?.T6XYGF;";H:DTYV0ZR2*O
M;1$. YC9_0XE+>W\8JW0#M*\\;M\INYR=*B3 ^W,A#Z/I!.=5GUS@Y#%TO]X
M/@"FEC&Z)L;(R-1)N?./K!PQ-R)3M) ;ERO'6U1TH..M<22!,8L$0N\+&" T
MM,1)3?>"J4UZ5 H =3%43CX2<2J03EYG%M<X(9AA9KLE-6(#0@\*$*()C>&A
MG)@4^BHH[GB/UMH>%?YZ\(4ZDDD:QRL,C*8E,HTPUQ*E):5?283NHF"!6=*2
MW0MB(^-8*[DXLZDM=7'*.3A68!MQB3)"@'ZM*$V\((+YR1#U,M<PDMZN1]?^
M0FO6$8^;V82R5AL2EF62D=U9!TT5&H:Q8H.WS0WRX0F;<;40,I=&V,SZD%C%
M1F[LM43!$$DR)-Q502Q1$>/!"MWBTKO3))N87G&J2RUH..RKW9F-QNR;C3B/
MA_H*$,R_.)G=W"3ED4+[V!TEF614A+ZY8823GRM@I,Y"J(3<Q S;<D%]. 2\
MI3$,.T:)JK95/V_<RA983%+9:A"W4S!$:W'N]>C[X:P-K): >TWMW&I]"6^<
M-_]I;^&O&$<D?)-WR85H6[#I)BF-8N)#><+8SG4YYVPJ/I*,:A5RVBM[6:AP
M9X:HTF'<4,.<_32ZE57U[T4!^^QRCN?3N>2O^8%KSC;E3ZS.N;DA&!Z86#!T
M/S4X.-9*M)%.26YMO$>"QC^PIW7OUM/ZC5J_H55  $N<HN(5I^.-B]V]BJD5
M?9ZP(F&[;[N+J[(BD%]2#=1*Y;RUM#4F3@&2;4)8V\ Y"DZRG.?".;AE$D>@
M$+!+@9M1>I^:;>6F:UIWV@EK8TVNV&HP8-I,P1RU"](WP!R2"K)8%#2V)65!
MB?4;:XM'4@'Y;8)>F)6K-"H=9_E( 5:AQ$@F!'5/W &AJ+C.<WAF:[U)4)'K
M8X 62LWOM]](MFHB$:0FPAICTC:H ;6I(#D _<CY4SX%B(C9G%_%2@VZDZU]
MS9F?2!(-^9R9<%9- $-.(;;*G2,#DCN7.G];Z>=E4QM?K^UR-F!;P;3%YID3
MB/,JE+H>:3.U%_LM8S I$7,FGP1L Y0Q8^.:SS-V;E&?O%&!TH8+(0G?+Y54
M9W-<^P$-6!QP+M&9$IK9=K(%B^W,G'5:';F'4B>]9C8WCEA#<RY]R:S^H/P(
MN.Y/9(RYO?9 %#S_A3+JJ<4/ ]SY\'9.KVF\Q\GYYLMB>4/ \>XZ*$C5.#(N
MTVJDD?1% ;.5!R5/^1FU4+%YD0ZF3$8K7$*5L4-M#WKE0ZLE6;:H+.Y'7I@L
M*S;-)%M99F'#'@ZMK38(9H%<>T7 VD[&5').?D<T\+-L%A-+K:H"V+!D \BA
MH($T+QO(W)0L YLDH9^24^NX+,+:)3,*\\]<IH4W@]([&%PQUTZR7BTHFO"6
MQA M9P)W-//1.T@X]N!G-I/Z_,5Q=*)R\LN&'5MY!\T5D5.N?RGMU[:RXFS!
M-B51QZLM62TW@"E)(EOG/P(#JHUX%_ZMG(8ZFMP&-=>.F 808+M48^0G_@%U
M.B"_L;?O#I\.BP(*NE=4PF9S1[&[K0:"F+D"#5MK(5%<9DB<A0+*2H23G*0]
M3JD W]&'Y*XZUF$(G*/!&30-=+V?Q%P[8*OYV ,_S'0(V'2 ,)!R%+*4EQM>
MY4FG=MHI;RKWA<7*BL1S[B.BF&GBA\&Z M.2/(YB5!>'2=?HQ6EZ:"&]L[?&
M!EW:>>&>-CQ(ZXM4@JIZRHE=-R\U5@L)_T+?,XV0W_HAO1YCK"9@^'7IXU>Q
MW/Y/X']?Y<VXRB3^^_GABV//U8)EM9-)<;&#<<7_^7'MXONW=O%UUCH<'L'T
M3XX.CH^CW]\>?#KX\";V;;:&_9%5?OX JX!:'ZZL1D6! @X>F\A2,@ #I74E
MU8SW'.EU4J*F/-I2V7,22;3EST_V7[X[B%X=O'MW_''_U>'1K_^\<^\._?OC
M_NO7YM]R< _PW%Y^^/3ZX!-]++/B3^["8;_;_WA\\-3\I7='F]N/Q\E4>?+I
MA?SEM:68O9] #__YY+7[YC]E+;Q:1UOF0?\%CW\QG\-_/JFAS!H4>6?DSW^:
MD-UVR34T)@<G YOY ??V".\%VA*O#]Z]VC]Y&QW_<7QR\/XXC@Z/7NUP-KJ9
MGC\U-88:XNW!X:]O3V#!C_P%J\_=R'MW.M_^[1;^XN7BJ9Y9X\0L;;:?H%^O
M?+=W\:-!48(0<Q]]09$)R_C'/?K?)2^[NC9_M4,Y2J;I[;%\=\=R@@;'7^E<
M4.L@X?*"M8\;5"Q#.IUST8AZ5_WH^MV#6_WNF]*,(QDT"%^_ I']Z=.^(YIO
M::40EW83> IC_?;BW_[Q>/?)PV??Q1_/?_[MQ;??!>],8#?VY_594<*/1Q%_
M7G!N .\2'LW3:.6-VKNWV_O=S2S1''1H:9=8S/=_EB?<MG"M*Z4_'K@%_Y!\
M_^$MW[_&[<1JHJ.C@_^*]K^Z(OB*PW]\MW\4?7@3O3X\/OET^/*WD\,/1]=2
MG7QI%P<YPP-]06(3*@A\1QV'.%CL-_[P0!.X0RZW!**4-GF(\\$V-WHRPI:F
MC+FT8ECX78/W*RED)I-LFBRD5U&=33F%&/Z,N>FOR>NT:>TP8[4:0DI(+0:
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M(\".W'ML86ZS1!10BWG)+;W=TELOHV-K!YN+.1-&JXJW!'1+0'T$Y+<^J<Y
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M!FV>QBM78A*:CGS77&O2Z5 AITQH\^C!8_-@\X4FM.:]5J'P*,?"@]V''8G
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M/&M<P-T?'%\,SCZ+6]J78K>26J!W:T4&=/9) OR8+M<"_A>TZ%%2+14;9]T
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MES>YF6A3X4TN,,]8K%.5=H$],-6/B.KWQ1 R>KVB? L%>+6CM*23TNI NVN
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M>,+7&!1Y^BTH<I_&^V'=95<PH;-R2;390&7L]T-+/<&X;;M3LNDV.#+P&<C
MC1<]);VMA)'^J J;G(]LS%?1AUB)_Q%\$8T Y4D)LEDK:?([C#^@X+0\#LI#
M? FJ&WXUYRAYL[.3?RTX$>]D!3N.Q]T.>Y3:EO(=2CH[!='#)@?^&G>"'\_S
MDCQF.M[#:\,JM>CQPR>%:,^4UKB-4XJ95RAI9TM2MH1B2"R.8V2&RH7"49>B
MU$D5QB\]2J-%J?@P*79QN=/M ,DP*I(&'3\A/38+TH2D+(" CAN)YGGZ/@,U
MA!W,6VT&E:M *C]0\[\6<2EN3/XBBY%,*LN$P?WV?(M'+ PGV+0>X!'<L!56
MR<:0HAXUS9]R_%[L/'L21%LS> P/[[>\^!#L8[P2M]-# GN^\^1),&][H@>6
MW["'8NKD8O^_]A J_,>O=9/9QNA5GBYF*,O0\X0[ $48..\-6"9F0XJYH+;;
M68%;#Q['8P% CU:3"-V]1FS3><N>&EZ#YM2$-U)JVF@\1WUD\ W>_M,D^Q"<
M@*6O2&&#_/ME A<LPMR5:91)O@3GC$[C;(0QW-$H%M,XI\37R2(;52JHPV\A
MSD,P]?@$9GE9D8<3^)BA[W:/=9EK>$,RML8*?QD'@'5Z3!E*\"7!?"_:"&?J
MDJ[2O#IY+.P[#[H+,IYY3-P'3ZZ(@#5CX#=.@=FQ])GFP$GA12 S')^^Z$6S
MZ$^.O6/"#DK<V/ 0S?OI*.RX)YX@1\F 4G2L#=4Z-_[!V]1/PHZ19^.OXX\
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M8FR\>2WV))U_LY:'\+9IGJ&)HWDVKZ_;H;]R'0VZ3%1XE#*V(KO.EUS2MT'
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MHEAJ9*@4ZA9=K=N18@].I")MT/&TL,N-9\[<'K+5&J)YI_&UU)9<,W1B$G9
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M7>K4<OK;J3[\J2H&_+_P3$U*6]#L/7SU>._DX#?X\,W%VZ/=_P%02P,$%
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M$W8F$[6T"\P;0LVPI?>MK.P3MSZD]5S/ D[&YO)@+)6XBW!/M?+S;G-OAT+
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M'[0[N[O-61H&%,9E[_DAYAM>W=Z<]!]\T_40R.FVZ'-9+/)7MO\%4$L#!!0
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M"X<ZA8XPMC#%#T6Z8'U(%0EO50;*=2 K!&DE9]#;-E$&_IE.4-&_DG)%A/L
M&'1>QAA4&S0/PUX\XDA4:+<U&%FY5N>C)4>U4]+(%L[*2'\XG= D;KPJ\C&O
MXQ61>P:X^3C&2LA=+:R+FF(AH5*'5!YM!21NO\;5CQ9-NX$Z$8'^TH2[[6+*
MK2_!GR1UA*BY=6XXZ *G00B)S%P9,FEG*EMHM(RD;;<8CT4N%D3,5+'?!5\G
M<_4:O@Q8P_6/%1*=/ABIM\4/AKH_&JF1Q7TV4A2"K!+DI9 >C;1HP_!LQ-9+
M><>UVM)?N9+OHMD7CZ@]_P-02P,$%     @ XH-S6+G#U1C'!   /BP  !4
M  !D8W1H+3(P,C0P,S$T7W!R92YX;6S5FF%OXC88Q]^?=-_!R]YLTD((]+85
MM3TQVDYHM$7 ;=/>G$SR -8<&]FFP+??XX!W!$(/>K<I[HL"CO^/_WY^QHF-
MK]ZO,DZ>06DFQ740U^H! 9'(E(GI=;#0(=4)8P'1AHJ4<BG@.EB##M[?O'US
M]4T8DMO[[B,)R<R8N6Y%T7*YK*43)K3D"X,A=2V1643"T-7OC#Z0WS?-M<@
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M 0 1              "  3BH  !D-S@T,S4T9&5X,3 R+FAT;5!+ 0(4 Q0
M   ( .*#<UCDG_\.AD   .4X 0 0              "  9_Z  !D-S@T,S4T
M9&5X-#$N:'1M4$L! A0#%     @ XH-S6+1BF[H/#@  ;"L  !$
M     ( !4SL! &0W.#0S-31D97@Y.3$N:'1M4$L! A0#%     @ XH-S6 IS
MOSP[ P  2@L  !$              ( !D4D! &1C=&@M,C R-# S,30N>'-D
M4$L! A0#%     @ XH-S6$3A'*]_!@  ND8  !4              ( !^TP!
M &1C=&@M,C R-# S,31?;&%B+GAM;%!+ 0(4 Q0    ( .*#<UBYP]48QP0
M #XL   5              "  :U3 0!D8W1H+3(P,C0P,S$T7W!R92YX;6Q0
52P4&      @ " #\ 0  IU@!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>d784354d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dcth-20240314.xsd" xlink:type="simple"/>
    <context id="duration_2024-03-14_to_2024-03-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
        </entity>
        <period>
            <startDate>2024-03-14</startDate>
            <endDate>2024-03-14</endDate>
        </period>
    </context>
    <dei:SecurityExchangeName
      contextRef="duration_2024-03-14_to_2024-03-14"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-320">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-03-14_to_2024-03-14"
      id="Hidden_dei_EntityCentralIndexKey">0000872912</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-331">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-332">2024-03-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-333">DELCATH SYSTEMS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-334">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-335">001-16133</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-336">06-1245881</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-337">566 Queensbury Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-338">Queensbury</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-339">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-340">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-341">12804</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-342">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-343">489-2100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-344">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-345">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-346">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-347">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-348">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-349">DCTH</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-03-14_to_2024-03-14" id="ixv-350">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
